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Resumo 
No presente estudo investigamos os efeitos de duas modalidades distintas de 
exercício (actividade física voluntária em roda livre –FW e treino em tapete 
rolante – Tm) em animais alimentados com duas dietas isocalóricas diferentes 
na percentagem de energia proveniente de gordura e de hidratos de carbono: 
Dieta Standard (SD) e Dieta Gorda (HFD) na bioenergética e stress oxidativo de 
mitocôndrias cardíacas. Ratos Sprague-Dawley machos foram divididos em 
quatro grupos: dieta standard sedentário (SD+SED, n=20), dieta standard roda 
livre (SD+FW, n=10), dieta gorda sedentário (HFD+SED, n=20) e dieta gorda 
roda livre (HFD+FW, n=10). Passadas 9 semanas, metade (n=10) dos animais 
dos grupos SD+SED e HFD+SED foram recolocados num novo grupo de treino 
em passadeira rolante (8 semanas, 5 dias/semana; 60 mins/dia; SD+Tm e 
HFD+Tm respetivamente). Realizou-se uma avaliação ex vivo de parâmetros de 
funcionalidade mitocondrial, sob condições de oxigenação normais e em anoxia-
reoxigenação, assim como semi-quantificação de subunidades da fosforilação 
oxidativa e avaliação da peroxidação lipídica e do estado redox da glutationa. 17 
semanas de dieta gorda não induziram qualquer efeito na funcionalidade 
mitocondrial cardíaca nem no estado redox. Contudo, o treino Tm promoveu 
melhorias na actividade respiratória mitocondrial nas duas dietas, antes e após 
a anoxia- reoxigenação. Já o treino FW aumentou o conteúdo das subunidades 
dos complexos IV e V da OXPHOS nas duas dietas, assim como melhorou a 
capacidade anti oxidativa mitocondrial (GSH/GSSG), particularmente no grupo 
HFD. Apesar da HFD não ter induzido disfunção na bioenergética mitocondrial, 
o treino Tm promoveu na generalidade um efeito mais visivel no consumo de 
oxigénio mitocondrial, enquanto que o exercício FW pareceu modelar de forma 
positiva a capacidade anti oxidativa mitocondrial. Concluímos assim que o 
exercício crónico pode constituir uma estratégia eficiente na melhoria da 
funcionalidade mitocondrial cardíaca num contexto de obesidade e HFD. 
PALAVRAS-CHAVE: EXERCÍCIO; CORAÇÃO; BIOENERGÉTICA; 
MITONDRIA; OBESIDADE. 
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Abstract 
We here investigate the effects of two distinct chronic exercise modalities 
voluntary free wheel training (FW) and the endurance treadmill training (Tm) in 
animals feed with isocaloric diets different in energy derived from fat and 
carbohydrates: standard (SD) and high fat diet (HFD) on cardiac mitochondrial 
bioenergetics and oxidative stress. Male Sprague-Dawley rats were divided into 
standard-diet sedentary (SD+SED, n=20), standard-diet free wheel (SD+FW, 
n=10), high-fat diet sedentary (HFD+SED, n=20) and high-fat diet free wheel 
(HFD+FW, n=10) groups. After 9-weeks, half (n=10) of SD+SED and HFD+SED 
groups were engaged in a Tm program (8 wks, 5 d/wk, 60 min/day; SD+Tm and 
HFD+Tm respectively). Ex vivo cardiac mitochondrial function endpoints were 
assessed under normal oxygenation conditions and anoxia-reoxygenation. Semi-
quantification of oxidative phosphorylation subunits, lipid peroxidation and the 
glutathione redox status were also measured. 17-weeks of HFD treatment, did 
not affect cardiac mitochondrial function neither the redox state (HFD+SED vs. 
SD+SED) Importantly, Tm exercise improved mitochondrial respiratory activity in 
both diet regimens before and after anoxia-reoxygenation. FW running increased 
OXPHOS complexes IV and V subunits in both diet treatments and improved 
mitochondrial anti-oxidant capacity (GSH/GSSG), particularly in HFD group. 
Although 17 weeks of HFD did not induced mitochondria bioenergetics 
impairments, Tm training had a stronger effect in overall mitochondria oxygen 
consumption, whereas FW exercise seems to positively modulate the antioxidant 
machinery. Overall, we conclude that chronic exercise may constitute an effective 
strategy to increase cardiac mitochondrial functionality in a context of obesity and 
HFD. 
KEY-WORDS: EXERCISE; HEART; BIOENERGETICS; MITOCONDRIA; 
OBESITY. 
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1. Introduction 
 
Obesity is one of the most prevalent diseases worldwide and has been 
considered a global epidemic (World Health Organization, 2015b). Despite of its 
complex etiology, obesity is frequently related to unhealthy behavior factors, 
including rich carbohydrate or fat diet and sedentary life style. The interaction 
between these two factors leads to a positive energy imbalance that has been 
believed to be the central cause of obesity (Lau et al., 2015; Ogden et al., 2007). 
Moreover, the hyperplasia and hypertrophy of adipocytes seen in an obesity 
condition ultimately culminates in adiposity tissue dysfunction, which is deeply 
associated to Cardiovascular Diseases (CVD) (Ferranti & Mozaffarian, 2008).  
Among several obesity-inducer models, a high-fat diet (HFD) consumption has 
been suggested to be responsible for cardiac and mitochondrial dysfunction as it 
is associated to increased production of reactive oxygen species (ROS), 
mitochondria respiratory chain (MRC) uncoupling, decreased oxidative capacity 
and calcium overload (Essop et al., 2016; Ferreira et al., 2015; Goncalves et al., 
2016; Sverdlov et al., 2015; Sverdlov et al., 2016). Importantly, most of the 
studies are concerned with the effects of a high-fat and high-energy diets. The 
fact that not only the caloric intake but also the diet composition is responsible for 
inducing obesity (Estrany et al., 2011; Goyal et al., 2012), justify the need to study 
the effect of HFD compared with an isocaloric control diet on cardiac 
mitochondrial function, a topic underexplored. 
Regular physical exercise has been considered a potential non-pharmacological 
strategy to counteract obesity, and also a potent cardio-protective therapeutic 
justifying its use within a clinical context (Ascensao et al., 2006; Bruun et al., 
2006; Golbidi & Laher, 2012; Hafstad et al., 2013; Huang et al., 2015; Pons et al., 
2013). Among the different animal exercise models, endurance training 
performed in treadmill (Tm) and voluntary free wheel running (FW) have been 
proven to be potential therapeutic and/o preventive strategies against cardiac 
mitochondrial dysfunction promoted by a variety of physiopatological conditions 
(Antonio Ascensao et al., 2011; Ascensao et al., 2006; Judge et al., 2005; 
Lesniewski et al., 2013). In fact, exercise training seems to positively modulate 
cardiac mitochondrial functionality, increasing antioxidant capacity, improving 
2 
membrane integrity and consequently improving oxidative capacity (Alleman et 
al., 2015; Jacobs & Lundby, 2013; Kavazis et al., 2008). However, there are still 
questions to be elucidated concerning Tm and FW exercise models. Differences 
in exercise intensity, volume, power, frequency, among other factors, can 
culminate in different cardiac mitochondrial adaptations.  
Therefore, our aim is to analyze the effects of two isocaloric diets (differing in 
energy derived from fat and carbohydrates) in cardiac mitochondrial 
bioenergetics and redox state. Additionally, to our knowledge, no studies so far 
analyzed if the effects of different exercise modalities with distinct characteristics, 
including intensity, volume and length (FW and Tm) in cardiac mitochondria are 
dependent on the percentage of fat consumption. To do so, heart mitochondria 
respiratory parameters were measured, which included oxygen consumption 
under normal oxygenation conditions and in anoxia-reoxygenation, and 
transmembrane electric potential. Oxidative phosphorylation (OXPHOS) subunits 
content was also determined. Finally, markers of mitochondrial lipid peroxidation 
(MDA content) along with parameters of antioxidant capacity evaluated by 
reduced glutathione (GSH), oxidized glutathione (GSSG) were quantified. 
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2. State of art 
2.1. Obesity: prevalence and etiology 
Nowadays, obesity is one of the most prevalent diseases in developed countries, 
and it has started to spread through less developed countries all around the 
world. Moreover, dramatic increases in obesity have occurred in both children 
and adults (World Health Organization, 2015b), becoming a global epidemic. 
According to the World Health Organization (2015b), more than 1.9 billion adults 
were overweight in 2014. Among these, 600 million where obese, which shows 
how alarming this public health problem really is.  
Currently, the WHO (World Health Organization, 2015b) defines obesity as an 
"abnormal or excessive fat accumulation that may impair health". The Body Mass 
Index, obtained by dividing the person’s weight (in Kilograms) by the square of 
his/her height (in Meters) (Bastien et al., 2014), has been largely used to classify 
overweight and obesity in adults. Therefore, a person with a BMI higher than 25 
is considered to be overweight and a person with a BMI higher than 30 is 
considered to be obese. However, BMI does not take into consideration the 
distinction between an elevated BMI due to high level of lean mass or due to high 
level of fat body mass nor the body fat distribution. Indeed, several studies 
confirmed that the regional distribution of body fat is much more important than 
excess adiposity per se regarding the CVD risk associated with a given excess 
of body weight/fat (for ref see Despres, 2012). Comparatively, markers of 
absolute and relative accumulation of abdominal fat, such as Waist 
Circumference (WC) and Waist-To-Hip Ratio have been used to underline the 
importance of abdominal fat as a serious health risk (Bastien et al., 2014). The 
use of imaging techniques as computed tomography and magnetic resonance 
(MRI) represent remarkable advances in the ability to precisely and reliably 
quantify individual differences in body fat distribution and to selectively distinguish 
subcutaneous adiposity from visceral abdominal adipose tissue (for ref see 
Despres, 2012). 
Regardless of its complex etiology, obesity is now considered to be the result 
from the interaction of various factors, such as behavior, environmental and 
genetic factors. The genetic seem to be the one that has less impact (Lau et al., 
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2015), being the stem cause of this problem the energy imbalance, meaning more 
calories consumed than expended. Determinants responsible for the increased 
caloric consumption counts increased portion size, consumption of sugar-
sweetened beverages, refined carbohydrates, advertising that promotes 
overconsumption. On the other hand, the reduced daily energy expenditure have 
been related to sedentary lifestyle, not only working time but also leisure time, 
both lacking of any sort of physical activity (Ogden et al., 2007). Therefore, the 
combination of energy-dense food products of poor nutritional value combined 
with a sedentary lifestyle has contributed to the emergence of obesity and the 
consequent health problems. 
This excess of energy is stored in adipocytes (fat cells), leading to hypertrophy 
and hyperplasia (Ferranti & Mozaffarian, 2008) and resulting in a dysfunctional 
adipose tissue, which is associated with an increased prevalence of metabolic 
disorders, enlarging the risk of diabetes, CVD and mortality (Dario A. Gutierrez 
et al., 2009). Indeed, HFDs are not only responsible for inducing obesity but also 
for leading to metabolic alterations in adipose tissue, increasing levels of 
circulating fatty acids (FA) in the blood, which ultimately contributes for the 
development of metabolic syndrome and CVD (Betanzos-Cabrera et al., 2012). 
In accordance, the American Heart Association has published several position 
statements emphasizing the health hazards of obesity (Cornier et al., 2011; Klein 
et al., 2004; Poirier et al., 2006). 
Although several strategies to control epidemic obesity have emerged, including 
the engagement with an active life style, it has been proposed that when 
compared, caloric restriction and dietary fat percentage reduction, the second 
option can be as effective as the first one in weight reduction and even more 
effective in improving insulin sensitivity along with others cardiovascular risk 
factors (Racette et al., 2006). 
The following sections will address the effects of obesity on the deregulation of 
adipose tissue function, as well as the link with CVD.  
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2.2. Obesity and Adipose Tissue 
Adipose tissue is composed by adipocytes and a vascular stromal fraction 
incorporating macrophages, fibroblasts, endothelial cells and pre-adypocytes. 
Pre-adypocytes, originated from a multi-potent stem cell, hold ability to generate 
new fat cells during the entire human life. The main roles of adipose tissue are to 
store energy in shape of triglycerides, insulate and cushion the body, this means 
control body temperature and mechanically protect the organs. This energy store 
results from free fatty acids (FFA) after food intake and it can be released during 
the fasting state, ensuring sufficient energy status (Hajer et al., 2008). 
Adipose tissue can be subdivided in fractions of subcutaneous and visceral 
adipose tissue with distinct functions. For instances, accumulation of intra-
abdominal or visceral adipose tissue has been reported to be quite deleterious 
and associated with a constellation of metabolic abnormalities increasing CVD 
risk (Despres, 2012). Although the visceral adiposity and liver fat are common 
key drivers of the cardiometabolic risk associated with overweight/obesity, other 
ectopic fat depots may also contribute to the risk of various cardiovascular 
outcomes (Despres, 2012). 
Nowadays, adypocytes are also known to generate peptides, hormones and 
cytokines, termed adipocytokines, with endocrine, autocrine or paracrine 
repercussion and controlling lipid and glucose metabolism, blood coagulation, 
inflammatory state, blood pressure and hormonal modulation. Therefore, adipose 
tissue is now considered to be an endocrine organ (for ref see Moura & Monteiro, 
2010) with a crucial relevance on body homeostasis. The consequences of 
obesity-mediated adipose tissue dysfunction will be addressed below. 
 
2.2.1. Inflammation and endocrine function of adipocytes: adipocytokines 
and obesity 
As stated before, obesity has been established as a chronic inflammatory disease 
that leads to adipose tissue dysfunction, culminating in CVD and metabolic 
diseases (Cancello, Rouault, et al., 2005). 
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Adipocytokines have an important role in generating feedback action, affecting 
metabolism and function of organs and tissues, such as muscle, liver, vascular 
and brain (for ref seeHajer et al., 2008). Some of the most relevant 
adypocytokines are: leptin, angiotensinogen II, interleukin-6 (IL-6), tumor 
necrosis factor  (TNF-), adiponectin and interleukin-10 (IL-10) (Moura & 
Monteiro, 2010). However, there are, at least, twenty four adipocytokines already 
identified (Hajer et al., 2008). 
In obesity, adipocytokines production is deregulated, leading to insulin 
resistance, energetic homeostasis disturbance, coagulation alterations and 
arterial hypertension (Arner, 2001). The table 1 summarizes the main function 
associated with a few relevant adipocytokines, obesity-related alterations in their 
production, reflected in plasma concentration, and its overall consequences at a 
systemic level.  
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Table 1. Obesity-induced alterations in Adipocytokine  
Adipocytokine Main function Obesity-induce [plasma] variations 
Systemic obesity-
induced alterations References 
Adiponectin 
• Anti-inflammatory marker 
• Upregulate fatty acid oxidation in 
muscle and liver 
• Protective role against atheroesclerosis 
• Downregulate hepatic gluconeogenesis 
 
• Insulin Resistance 
• Metabolic Syndrome 
• Type 2 Diabetes 
Hajer et al. (2007). 
Kadowaki & 
Yamauchi (2005) 
TNF- • Inflammatory marker 
• Upregulate lipolysis  
• Systemic chronic 
inflammatory state 
• Dyslipidemia 
• Insulin resistance 
Dario A. Gutierrez 
et al. (2009) 
Angiotensinoge
n 
• Vasoconstrictor  
• Arterial pressure regulator  
• Hypertension 
• Vascular stiffness  
Massiéra et al. 
(2001) 
IL-6 • Inflammatory marker  
• Insulin Resistance 
• Systemic chronic 
inflammatory state 
Wannamethee et 
al. (2007). 
Leptin* 
• Regulation of Adipose Tissue, trough 
appetite and food intake reduction 
• Upregulated catabolic paths: -
oxidation; glycolysis; 
• Mitochondrial biogenesis 
• Increase sympathetic tonus  
 
• Leptin Resistance 
• Increase heart rate 
• Increase blood 
preassure 
Moura & Monteiro 
(2010) 
Arner (2001) 
Turer et al. (2012) 
- upregulated; - downregulated *Leptin limits the excess calories store and blocks the development of chronic steatosis. In obesity, contrarily of what expected, 
the leptin production is up-regulated suggesting a possible leptin resistance, along with alteration in its signaling (for ref seeMoura & Monteiro, 2010).
8 
2.2.2. Impact of increased adipose tissue and inflammation on insulin 
resistance and dyslipidemia  
2.2.2.1. Insulin resistance 
Insulin Resistance (IR) is characterized by decreased insulin sensitivity, not only 
in the liver, but also in peripheral tissues. Moreover, it’s considered to be a 
precursor of Type 2 Diabetes Mellitus (Dario A. Gutierrez et al., 2009). As it was 
already mentioned, obesity is now established as a chronic inflammatory disease. 
This inflammatory state is assumed to contribute to IR by reducing insulin 
sensitivity in adipose tissue and other organs (Apovian et al., 2008). 
As a result of adipose tissue dysfunction and inflammatory state, the production 
of pro-inflammatory adipocytokines, such as TNF- is upregulated (Table 1). The 
TNF- contributes to insulin signaling defects resulting in increased nonesterified 
fatty acids (NEFAs) blood concentration and their storage in liver, muscle and 
pancreas, directly inhibiting insulin signaling pathways and culminating in a 
systemic IR (for ref seeDario A. Gutierrez et al., 2009). 
Besides TNF-, other adipocytokines can also contribute to lipid homeostasis 
(Table 1). In fact, leptin and adiponectin play an important function. For instance, 
leptin can upregulate FA oxidation, reducing lipid accumulation in other organs; 
however, it is thought that obesity can induce leptin resistance, thereby losing its 
protective role against IR. Adiponectin, which has also a protective role 
enhancing muscle fat oxidation, is down-regulated in obesity (Unger et al., 1998). 
In obesity, the increased plasma concentration of NEFAs and TNF-, the leptin 
resistance and the down regulated production of adiponectin contribute to lipid 
accumulation in the liver, muscle and pancreas, ultimately culminating in IR 
(Dario A. Gutierrez et al., 2009). 
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2.2.2.2. Dyslipidemia 
Dyslipidemia is characterized by elevated plasma NEFAs, triglycerides (TGs), 
low-density lipoprotein (LDL) and reduced plasma high-density lipoprotein (HDL). 
Obesity is considered to be a precursor of dyslipidemia, as an increased in 
adipocyte size can lead to adipocyte saturation and inability to store lipid excess. 
The uncontrolled fatty acid lipolysis from visceral adipose tissue, results in an 
increased delivery of fatty acids to the liver to act as substrate for very low density 
lipoprotein (VLDL) (Dario A. Gutierrez et al., 2009). 
Furthermore, as presented in Table 1, obesity is associated with an up-regulation 
of TNF-, which is able to upregulate lipolysis, resulting in an increased of 
circulating NEFAs and, consequently, their delivery to the liver promoting TG 
synthesis and VLDL secretion. Therefore, it is obvious that the increased 
secretion of TNF has a major impact in dyslipidemia (Jovinge et al., 1998). Also, 
in table 1, is mentioned that adiponectin is down regulated in obesity. Besides 
having a protective role against dyslipidemia, this adipocytokine is also 
associated with a lower plasma concentration of TG and VLDL and a higher 
plasma concentration of HDL. Consequently, the downregulated production of 
adiponectin increases the risk of dyslipidemia (for ref see Dario A. Gutierrez et 
al., 2009). 
The deregulated production of adipocytokines, a distinct characteristic of adipose 
tissue dysfunction commonly seen in obesity, is associated with the development 
of IR, dyslipidemia and chronic inflammation. The next sections will address the 
mechanisms and the consequences behind obesity-induced cardiovascular 
complications, including vascular stiffness, hypertension and associated 
myocardial complications and heart dysfunction. 
 
2.3. The relationship between obesity and cardiovascular complications  
The CVD are some of the most deadly and disability-induced diseases worldwide, 
affecting the heart and the blood vases. It is estimated that 31% of all global 
deaths are caused by CVD (World Health Organization, 2015a). They include 
coronary heart disease, cerebrovascular disease, peripheral arterial disease, 
rheumatic heart disease, congenital heart disease, deep vein thrombosis and 
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pulmonary embolism. Myocardial infarction and strokes are the ultimate outcome, 
mostly culminating in death. The main cause is the accumulation of fat within the 
blood vascular walls, known as atherosclerosis, which can cause a blockage in 
the blood flow, preventing blood from flowing to the heart and brain (Hobbs, 2015; 
World Health Organization, 2015a). 
Obesity is an important cardiovascular risk factor. It is now established that 
adiposity not only induces adverse local effects but also has a systemic effect 
(Ferranti & Mozaffarian, 2008). Moreover, obesity in now considered as an 
independent risk factor for CVD, suggesting that the increased adiposity indices 
are the main drivers behind the intermediate risk factors, such as vascular 
stiffness, hypertension, dyslipidemia, IR, chronic inflammation, diabetes mellitus, 
endothelial dysfunction and atherosclerosis (Bastien et al., 2014; Strasser et al., 
2015). 
 
2.3.1. Vascular stiffness, endothelial dysfunction and obesity-induced 
chronic inflammation 
Obesity and IR are known to interact and impair vascular function and structure, 
as they are linked to endothelial dysfunction, increased artery intima media 
thickness and increased vascular stiffness (Herouvi et al., 2013). The 
endothelium is a complex organ. It is responsible for the regulation of the 
smoothed muscle cells proliferation, platelet function, vasomotor tone and 
thrombosis (López-Jiménez & Cortés-Bergoderi, 2011).  
The first event of atherogenesis is the endothelial damage caused by various risk 
factors, such as arterial hypertension, hyperglycemia and dyslipidemia. The 
outcome of endothelial damage is actually endothelial dysfunction, which 
consists in an unbalance production of vasodilators agents and vasoconstrictors 
agents, with a decreased production of nitric oxide (NO) and an increased 
production of Ang II, respectively. Moreover, the production of ROS is also 
reported to be up-regulated (Husain et al., 2015). This contributes to an 
inflammatory state, along with an increase in intima membrane thickness (Figure 
1). 
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In fact, the main driver of atherosclerosis is the excess of circulatory cholesterol, 
more precisely of VLDL. As the ROS production is up regulated due to the 
endothelial dysfunction, the VLDL molecules become oxidized. Thereafter, the 
oxidized VLDL connects with receptor-1, which is also up regulated in behalf of 
Ang II, and it is able to get through the endothelium, ending up in intima media. 
Additionally, the proliferation of VLDL oxidized through endothelium amplifies 
endothelium dysfunction, resulting in an even bigger decrease of NO production 
(Allahverdian et al., 2012). Furthermore, oxidized VLDL induces endothelial cells 
apoptosis and the expression of intracellular adhesion molecule-1 (ICAM-1), 
vascular cell adhesion molecule-1 (VCAM-1) and selectin-P, which results in 
endothelial damage as well as in monocyte infiltration in the intima media, 
boosting the inflammatory state (Apovian et al., 2008; Pasceri et al., 2000) . 
 
Figure 1. “Proposed mechanisms of vascular stiffness in obesity, insulin resistance, and 
type 2 diabetes”. EC, endothelial cell; VSMC, vascular smooth muscle cell; AGE, 
advanced glycation end products; MMPs, matrix metalloproteinase; TG2, tissue 
transglutaminase; Ang II, angiotensin II; MR, mineralocorticoid receptor; TxA2, 
thromboxane A2; ENaC, epithelial Na+ channel; IL, interleukin; TNF, tumor necrosis 
factor; NO, nitric oxide; MCP-1, monocyte chemotactic protein-1; CRP, C- reactive 
protein; TGF-, transforming growth factor- ” (Jia et al., 2015). 
 
During the immune response and within the intima media, the macrophages (M1, 
M2) are not capable of fagocitating the VLDL oxidized, forming macrophage foam 
cells. This maladaptive immune response increases the cytokine production of 
TNF- and IL6, resulting in a continuous lipid accumulation along with chronic 
inflammatory state (Allahverdian et al., 2012). The atheroma plaque growth is the 
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result of an increased number of macrophage foam cells and lymphocyte, which 
up regulate the production of hydrolytic enzymes, cytokines and growth factors, 
leading to fibrosis and local necrosis (for ref see Allahverdian et al., 2012). At this 
point, atherosclerosis is settled, the blood flow is reduced due to the atheroma 
plaque along with the diminished endothelial vasodilatation capacity. Over time, 
the atheroma plaque becomes unstable, meaning an increased risk of rupture 
and, consequently, espousing its lipid content. This event is highly thrombogenic, 
ultimately resulting in myocardial infarction or in cerebrovascular accident 
(Apovian et al., 2008; Jia et al., 2014; Maiolino et al., 2015). 
Additionally, perivascular adipose tissue (PVAT) is also a serious risk factor for 
the development of obesity-induced atherosclerosis (Shimabukuru, 2009). 
Perivascular fat serves as a structure component present in most arteries and is 
defined as the accumulation of fat around vascular structures, mostly in the 
proximity of all blood vessels and around the coronaries and aorta (Shimabukuru, 
2009). This tissue is a source of molecules with varied paracrine effects, holding 
ability to modulate vascular responsiveness to vasoactive agents (Villacorta & 
Chang, 2015). In obesity, the expression and infiltration of pro-inflammatory 
immune cells in PVAT is increased along with a reduced expression of anti-
inflammatory factors (Aroor et al., 2013), which is associated with endothelial 
dysfunction. Therefore, obesity is considered an important risk factor for vascular 
stiffness and atherosclerosis with consequently adverse effects in several 
organs, including the heart, kidney, liver and brain. (for ref see Jia et al., 2015). 
Particularly, the compromised heart function and myocardial dysfunction linked 
with endothelial deregulation are addressed below.  
 
2.3.2. Obesity compromises heart structure and function  
Obesity is responsible for inducing structural adaptations in cardiovascular 
structure and function, in order to maintain whole body homeostasis. Stroke 
volume augmentation, which is thought to be a compensatory adaptation to 
increased adipose tissue mass (Szczepaniak et al., 2007), as well as the 
stiffening of central arteries increase systolic pressure and decrease diastolic 
pressure, and culminate in increased afterload. Over time, as a response to the 
higher cardiac workload, the ventricle starts to get thicker (ventricular 
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hypertrophy) so it can overcome the new demands. Further, the decrease in 
diastolic pressure is associated with reduced coronary flow during the diastole. 
These alterations are associated with left ventricular remodeling and fibrosis, 
leading to left ventricular-diastolic dysfunction and development of coronary 
artery disease (Jia et al., 2014; Lavie et al., 2009). 
Epicardial adipose tissue (EAT) is the visceral fat that is located between the 
outer layer of the myocardium and visceral pericardium (Shimabukuru, 2009). In 
a similar way as abdominal adipose tissue, EAT also has considerable secretory 
activity. It has been reported that the increased EAT volume (commonly seen in 
obesity) directly compromises myocardial metabolism (Rosito et al., 2008) and is 
associated, among others, to the overexpression of pro-inflammatory TNF- and 
IL-6 (Kremen et al., 2006). Additionally, due to the proximity to coronary arteries, 
EAT has been linked to increased atherosclerosis burden (Shimabukuro et al., 
2013), increasing even more the risk for cardiac structural and functional 
impairments.  
Alongside with vascular alterations that induced cardiac functional and structural 
disarrangements, obesity also promotes fat infiltration into the myocardium 
(Powell et al., 2006). Lipid over-accumulation in cardiomyocytes can result from 
increased FA uptake, decreased FA oxidation or even a combination of both 
(Szczepaniak et al., 2007). In obesity conditions, when adipocytes reach their 
maximum storage capacity, plasma FFA concentration increases, resulting in an 
ectopic accumulation of lipids in non-adipose tissues, including the myocardium 
(Szczepaniak et al., 2007). Therefore, myocardial fat infiltration is associated with 
several cardiac complications, including healed myocardial infarction, 
arrhythmogenic cardiomyopathy, dilated cardiomyopathy and cardiomyopathy 
with muscular dystrophy (Komatsu et al., 2014). In fact, this link between obesity 
and the severity of myocardial disease has been demonstrated in various studies. 
It has been proposed that an increased prevalence of myocardial fibrosis is 
proportional to the degree of obesity and is associated with cellular degeneration 
and inflammation (for ref see López-Jiménez & Cortés-Bergoderi, 2011). It is also 
suggested that the longer duration of morbid obesity, the greater the left 
ventricular mass and the worse the impairment of left ventricular systolic function 
and diastolic filling (for ref see Szczepaniak et al., 2007). Also, the over-
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accumulation of lipids in the cardiomyocytes induces steatosis of the 
myocardium, ultimately leading to lipotoxic cardiomyopathy (Szczepaniak et al., 
2007). 
 
2.3.3. Adipocytokine action on the heart: the particular case of leptin 
Several key metabolic hormones have important central inputs besides the well 
known peripheral effects. Leptin is one good example of this fact, as it is known 
to have the ability to regulate sympathetic nervous system (Turer et al., 2012). 
Although the precise mechanisms by which leptin regulates autonomic nervous 
system (ANS) are still unclear, it is accepted that leptin plays as important role on 
cardiovascular regulation and that is a link between excess weight gain, 
increased sympathetic tone and hypertension (Bassi et al., 2015; Wang et al., 
2013).  
Circulatory leptin levels provide information regarding energy expenditure and 
amount of fat stored. This information is centrally processed by the ANS, 
regulating food intake and energy expenditure. Therefore, if leptin levels are 
elevated due to obesity, one mechanism able to increase energy expenditure is 
the augmentation of sympathetic tone (for ref see Barnes & McDougal, 2014). 
Sympathetic tone stimulation has profound impacts in cardiovascular function, 
including arterial blood pressure and heart rate (Correia et al., 2000). Additionally, 
leptin also upregulates blood pressure through increase of renal sympathetic 
nerve activity (for ref see Barnes & McDougal, 2014). 
Additionally, Wang et al. (2013) demonstrated a relation between circulatory 
leptin levels and endothelial dysfunction, in which leptin enhances the effects of 
ang II on blood pressure. According to other studies, these effects of leptin are 
mediated by sympathetic nervous system activation and contribute to vascular 
stiffness and hypertension in obesity (for ref see Brooks et al., 2015). 
 
2.3.4. The obese myocardium: lipotoxicity and metabolic disarrangements 
Lipotoxicity can result from FA accumulation in the heart induced by excessive 
FA consumption. Fat infiltration in the heart leads to an alteration in substrate 
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preference and utilization towards FA metabolism (Hall et al., 2015). This means 
that the heart no longer has the ability to transit between FA metabolism to 
glucose metabolism, under energetically demanding conditions, which results in 
energy imbalance, impaired contractility, and post-translational protein 
modifications. This is known as a central trait of obesity-induced cardiometabolic 
disease (Griffin et al., 2015). This metabolic alteration is promoted by an increase 
in the expression of proteins involved in fatty acid oxidation, including carnitine 
palmitoyltransferase-1 (CPT1). As a result of this FA oxidation alteration, toxic 
lipids, including ceramide, are formed, contributing for cardiac dysfunction (Park 
et al., 2008; Slawik & Vidal-Puig, 2006). 
Several studies have demonstrated that toxic lipid accumulation in myocardium, 
such as ceramide, is associated with an increased in the inflammatory marker 
TNF- (Sharma et al., 2004) and the production of ROS leading to insulin 
signaling impairment, which ultimately results in cardiac IR (Murphy & Brown, 
2009) and cardiac contractile dysfunction by influencing sarcoplasmic reticular 
calcium stores, promoting mitochondrial dysfunction and, at last, cardiomyocyte 
apoptosis (Listenberger et al., 2001; Turer et al., 2012) . 
Cardiomyocyte death, the ultimate result from myocardium fat infiltration, is 
recognized as a critical and direct factor in the development of heart dysfunction. 
Among the several molecular mechanisms associated with obesity-induced 
cardiac dysfunction, mitochondrial abnormalities seem to have a central role. As 
mitochondria integrity preservation is absolutely essential not only for maintaining 
metabolic homeostasis but also for survival of cardiomyocytes (Murphy & Brown, 
2009), these organelles are fundamental to a proper cellular functioning. 
Moreover, as cardiomiocytes depend entirely on healthy mitochondria for normal 
heart function, mitochondria are reliable sensors of cellular homeostasis. Indeed, 
(dys)functional mitochondria correlates with (dys)functional cardiac tissue 
submitted to a variety of stimuli, including obesity. Heart mitochondrial structure 
and function and its relation with obesity are addressed in the following section.  
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2.4 The heart mitochondria  
Mitochondria are essential organelles situated in the cytoplasm and associated 
not only with energy production, but also with ion regulation, osmotic regulation, 
pH control, calcium homeostasis, redox reactions, cell signaling and regulation of 
programmed cell death, thus assuming pivotal role in cellular function (Antonio 
Ascensao et al., 2011). Therefore, in the present thesis, a brief description of 
mitochondrial-mediated mechanisms associated with cell function will be 
accomplished before obesity effects on heart mitochondria.  
In cardiomyocytes, there are two distinct types of mitochondria with distinct roles 
in cardiomyocyte physiology. Considering the energy demand of cardiomyocyte 
for the heart beat maintenance, the energy source is assigned by these two 
distinct mitochondria, depending on its final use (Pereira, 2012). There are 
mitochondria closer to the T tubules and to sarcoplasmic reticulum that provides 
energy (ATP- Adenosine Triphosphate) for the required calcium influx to the 
sarcoplasmic reticulum. In fact, this energy source is essential for calcium 
homeostasis, which is critical for the relaxation and contraction cycle. 
Additionally, there are also cardiac mitochondria pivotal to energy source and 
responsible for the release of myosin from actine and consequently for the stroke 
force (for ref see Pereira, 2012). 
As a result of the high energy demand of the heart, a refined mitochondrial quality 
control is needed, this means that non-functional or damage mitochondria are 
removed by auto(mito)phagy and new healthy mitochondrial are formed by 
biogenesis. Both situations depend on fission and fusion events, and can occur 
in certain pathological situations. For example, very small/ fragmented 
mitochondria can be found in dilated cardiomyopathy and ventricular-associated 
congenital heart disease, or large and defective mitochondria in aged 
cardiomyocytes (for ref see Pereira, 2012). 
Although heart mitochondria might be slightly different in morphology they both 
have the basics characteristics of mitochondrial from other tissues. 
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2.4.1. Mitochondrial structure 
Mitochondria have two membranes with distinct function, the outer mitochondrial 
membrane (OMM) and the inner mitochondrial membrane (IMM), being the space 
between the two membranes called inter-membrane space. These two 
membranes separate the cytoplasm from the mitochondrial matrix, where 
mitochondrial DNA (mDNA) is found. Indeed, mitochondria are the only 
organelles, besides cell’s nucleus, that have their own DNA (Pocock & Richards, 
2006). 
The OMM is highly permeable due to the presence of transmembrane channels, 
such as porins and protein complex known as translocase of the outer membrane 
(TOM), which allow the passage of proteins to the inter membrane space. 
(Pocock & Richards, 2006). The structure of the IMM is characterized by its folded 
aspect due to the presence of invaginations, formally known as cristae. These 
invaginations significantly increase membrane surface. In contrast to the OMM, 
the IMM is less permeable, which means that it is selective permeable to certain 
molecules depending on specific carriers (Pocock & Richards, 2006). Importantly, 
inserted in the inner membrane it is located the MRC pivotal for the mitochondrial 
energy production.  
 
2.4.2. Mitochondrial energy production – oxidative phosphorylation 
The OXPHOS is a metabolic pathway in which energy produced by 
oxidation/reduction reactions is used for the phosphorylation of adenosine 
diphosphate (ADP) to ATP (Kadenbach, 2003). The process begins with the 
production of reduced equivalents, reduced nicotinamide adenine dinucleotide 
(NADH) and flavin adenine dinucleotide (FADH2) in the Krebs cycle and beta-
oxidation. The main role of these two elements is to give way electrons to the 
MRC (Johannsen & Ravussin, 2009). 
The MRC is inserted in the inner membrane and constituted by five protein 
complexes (I-V) (Table 2). Some of these complexes are responsible for the 
transportation of protons (H+) from the mitochondrial matrix to the inter-
membrane space, producing an electric potential that is of particular relevance 
for ATP producton () (Kadenbach, 2003). 
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Both processes (electron transference and directional proton transportation) are 
intrinsically bounded. As complexes I, III and IV get oxidized (receive electrons) 
they pump H+ to the inter-membrane space, complex I pumps four H+, complex 
III also pumps four H+ and complex IV pumps two H+, resulting in the 
transportation of approximately ten H+ (Kadenbach, 2003). Although, this only 
happens if the first electron accepter is complex I (NADH dehidrogenase - as it 
receives electrons from NADH), originated in Krebs cycle, It is also possible that 
the first electron receptor is complex II (succinate-dehidrogenase: ubiquinone 
reductase - as it receives the electron pair from FADH2) excluding complex I from 
the chain. If this occur, it can result in the transportation of approximately six H+ 
to the inter-membrane space, four H+ less than with complex I as the first point of 
electron entry in MRC (Johannsen & Ravussin, 2009). 
The transference of electrons (oxidation/reduction – redox reactions) along the 
complexes (I-IV) is conducted by the decrease in their redox potential, until they 
reach their final acceptor, oxygen (O2), in complex IV, forming water (H2O) 
(Johannsen & Ravussin, 2009). Therefore, mitochondria produce ATP in an 
aerobic way, meaning in the presence of O2. 
At the end of the MRC, implicating that the electrons have already encountered 
O2, the electrochemic gradient is amplified, due to the transportation of H+ to the 
inter-membrane space. This results in a returning tendency of H+ from the inter-
membrane space to the mitochondrial matrix. Complex V (ATP- syntase) allows 
the protons to return to the mitochondrial matrix, originating a protomotriz force, 
which activates ATP synthesis (ADP+Pi) (Johannsen & Ravussin, 2009). For 
each four H+ reentering the mitochondrial matrix, one ATP will be phosphorylated, 
this means, in averaged, that for every electron pair provided from NADH, which 
results in 10 H+ pumped to the cytoplasm, 2,5 ATP are formed, and if the pair of 
electrons are provided from FADH2 it will be formed 1,5 ATP (Hinkle, 2005). 
As ATP is formed, it has to be transported to the inter-membrane space through 
adenine nucleotide translocase (ANT), which is also responsible for the reentry 
of ADP needed for ATP re-synthesis. Furthermore, the ability to ATP reach cell’s 
cytoplasm through the OMM is dependent of the presence of non-selective 
channels designated as voltage-dependent anion channel (VDAC) (Johannsen & 
Ravussin, 2009). 
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Table 2. A brief resume of the mitochondrial respiratory chain complexes 
Complexes Function References 
I – NADH dehidrogenase: 
Ubiquinone/Coenzyme Q 
(CoQ) Reductase 
First point of entry of electrons 
into MRC; 
Oxidizes NADH and reduces 
ubiquinol to ubiquinone; 
Pumps 4 H+ to the inter-
membrane space. 
Johannsen & 
Ravussin 
(2009) 
II – Succinate 
Dehidrogenase: Ubiquinone 
Reductase 
First or second point of entry of 
electrons into MRC; 
Converses succinate to 
fumarate in Krebs Cycle. 
Johannsen & 
Ravussin 
(2009) 
III – Ubiquinol: cytochrome-
c reductase 
Catalysis the transference of 
electrons from 
ubiquinol(oxidation) to 
cytochorme-c (reduction); 
Pumps 4 H+ to the inter-
membrane space. 
Johannsen & 
Ravussin 
(2009) 
IV – Cytochrome-c: Oxygen 
oxidoreductase 
Catalysis the transference of 
electrons from cytochrome-c 
(oxidation) to O2 (reduction), 
forming H2O; 
Pumps 2 H+ to the inter-
membrane space. 
Johannsen & 
Ravussin 
(2009) 
V – F0F1 -  ATPase Uses the amplified proton 
gradient (protomotriz force) to 
synthesize ATP 
Johannsen & 
Ravussin 
(2009) 
MRC- mitochondrial respiratory chain; NADH- nicotinamide adenine dinucleotide; O2 - oxygen 
;H2O- water; ATP- adenosine triphosphate 
 
2.4.3. Mitochondrial as source of oxidative stress 
The OXPHOS in MRC is one of the major redox system in the cell and responsible 
for a significant amount of free radicals production (Ray et al., 2012). Free 
radicals are defined as any molecule with one or more unpaired electron and 
capable of freely exist and highly reactive in a way that they are able to “attack” 
any biomolecule or biological structure (Kehrer & Klotz, 2015). Free radicals are 
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a result of normal cellular aerobic metabolism and represent a physiological 
consequence of O2 use. However, there are situation where this compound 
formation is deregulated, meaning that they can exist in a free form and interact 
with various biological structures, ultimately resulting in injury. Importantly, these 
molecules trigger important signaling events, both directly and through various 
redox-regulated transcription factors (Ray et al., 2012). 
Kehrer & Klotz (2015) feature radical’s basic reaction characteristics in three 
categories: Initiation reactions, where the numbers of radicals increase, these 
reactions involve O2 reduction; propagation reactions, involving hydrogen 
abstraction, electron transfer or addiction and where the number of radicals does 
not change; and termination reactions, resulting from the interaction of two 
radicals, reducing the number of radicals until they disappear.  
The prevalence of oxygen in mitochondria induces oxygen-centered reactive 
species production, formally known as ROS (reactive oxygen species, 
abbreviation previously defined), which include superoxide radical (O2.-), 
hydrogen peroxide (H2O2), hydroxyl radical (OH.), among others (Kehrer & Klotz, 
2015). Besides MRC, there are other redox-related system located in several 
places of the cell, including endoplasmic reticulum, peroxisomes and cytosol. 
The damaging effects of ROS have been demonstrated along the years of 
experiments and investigation. Nowadays, there are also evidences regarding 
the beneficial effects of a controlled ROS production. Actually, ROS are 
responsible and imperative for regulating several cellular mechanisms, including 
mitochondrial biogenesis and apoptosis, which are pivotal processes for cell’s 
health maintenance, along with others cellular signaling pathways (Cadenas, 
2004; Finkel, 2001). However, an additional ROS production can be implicated in 
several physiological and pathological conditions, including aging, DNA 
mutagenesis, inflammation and cell death pathways (Kehrer & Klotz, 2015). The 
deleterious effects of ROS in lipids, proteins and DNA are addressed bellow. 
Lipid peroxidation has a pivotal effect in terms of ROS mediated injury, justified 
by lipid’s critical structural and functional role in cell’s membrane (for ref see 
Kehrer & Klotz, 2015). In addition, the protein oxidation is associated with age-
related losses of selected biochemical and physiological functions that may be 
related to unrepaired damage to other macro molecules, such as DNA (Baraibar 
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et al., 2012). In fact, the DNA oxidation affects the integrity and regulation of 
genes, which may be harmful or beneficial to cells. These changes can result 
from direct modifications to DNA or may be due to changes in transcription factors 
or enzymes involved in gene expression and repair (for ref seeKehrer & Klotz, 
2015). When DNA repair processes are affected, it can culminate in permanent 
DNA damage as it can modify DNA sequences, also known as mutations 
(Regulus et al., 2007). 
As already mentioned, the main source of ROS in mitochondria is the MRC, more 
precisely, complex I, II and III (Kornfeld et al., 2015). This complexes promote O2 
reduction to O2.- (superoxide anion), a highly reactive specie and a precursor of 
other ROS, such as H2O2 (hydrogen peroxide) and OH: (hidroxil radical) (Ray et 
al., 2012).. Normally, this happens in a controlled and caged form due to the 
presence of antioxidant molecules that are responsible for maintaining ROS 
production balanced. Nevertheless, there are conditions where the production of 
pro-oxidant molecules and antioxidant molecules is imbalanced, resulting in what 
is known for oxidative stress (Kehrer & Klotz, 2015). The more recent definition 
of oxidative stress is featured in Kehrer & Klotz (2015) work as “an imbalance 
between oxidants and antioxidants in favor of the oxidants, leading to a disruption 
of redox signaling and control and/or molecular damage” (for ref see Kehrer & 
Klotz, 2015). 
Antioxidants are in permanent activity as ROS production is also permanent, as 
a result of aerobic metabolism. There are two different types of antioxidants, 
enzymatic and non enzymatic. Furthermore, they can also be classified according 
to their action against free radicals: scavenger antioxidants are able to turn a free 
radical into another less reactive free radical and quencher antioxidants able to 
completely neutralize free radicals (Kehrer & Klotz, 2015). Enzymatic 
antioxidants present in mitochondria will be addressed below. 
Enzymatic antioxidant defense systems include superoxide dismutase (SOD), 
catalase (CAT), glutathione peroxidase (GPx) and glutathione reductase, among 
others (Figure 2): 
• The SOD are a family of metalloenzymes that are able to convert two 
superoxide anions to triplet oxygen and H2O2. Bearing in mind that H2O2 is 
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less reactive than O2.-, SOD’s role is simply to turn a highly reactive radical 
into a less reactive one. Mitochondrial SOD is manganese SOD (MnSOD) 
(Kehrer & Klotz, 2015). 
• After superoxide dismutase, both CAT and GPx are able to cope with H2O2. 
CAT catalyzes the dismutation of H2O2 to water and molecular oxygen and it 
is essentially located in peroxisomes and its action is potentially diminished in 
the heart, lungs and brain, due to their reduced peroxisome presence 
(Kornfeld et al., 2015). 
• The GPx is located in cytoplasm and in mitochondria. It catalyzes H2O2, using 
glutathione (GSH) as substrate. GSH transfers two H+ to H2O2, forming two 
water molecules. As GSH gives away electrons, it gets oxidized, becoming 
glutathione disulfide (GS – GS). In order to reduce GS – GS into GSH de 
novo, NADPH/ FADH2, from Krebs cycle, transfer electrons to GS –GS, 
forming GSH, this reaction is catalyzed by Glutathione reductase. Bearing in 
mind GPx action, as it neutralizes completely H2O2, it is acknowledged as a 
quencher antioxidant. GPx is present in various organs, including the heart 
(Herbet et al., 2015). 
 
Figure 2. “Antioxidant enzyme 
system. The SOD convert 
superoxide radical into hydrogen 
peroxide. The CATs and GPXs 
convert hydrogen peroxide into 
water. In this way, two toxic species, 
superoxide radical and hydrogen 
peroxide, are converted into the 
harmless product water. GPX 
requires several secondary 
enzymes (GR and G-6-PDH) and 
cofactors (GSH, NADPH, and 
glucose 6-phosphate) to function. In 
this scheme, GR and G-6-PDH are considered secondary antioxidant enzymes, because 
they do not act on ROS directly but enable GPX to function.” (adapted from Li et al., 
2000). 
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2.4.4. Mitochondrial calcium homeostasis and apoptosis 
Mitochondria are essential for the maintenance of cytosolic calcium homeostasis, 
as they are able to accumulate calcium through an electrochemical gradient that 
favors transport across the IMM (Gustafsson & Gottlieb, 2008). Mitochondrial 
mechanisms of calcium uptake and release have been studied along the years 
and include, the mitochondrial calcium uniporter (MCU) and the sodium calcium 
exchanger (NCX) (Carafoli, 2010). However, other pathways remain to be 
elucidated, such as the mitochondrial permeability transition pore (mPTP) 
(Bernardi & Di Lisa, 2015). Calcium homeostasis and mitochondrial permeability 
transition will be addressed below. 
As it is already mentioned above, mitochondria play an important role in calcium 
homeostasis, constituting a calcium buffering system. This mitochondria role is 
pivotal for cell’s health since elevated calcium concentrations may be deleterious, 
justifying the necessity of maintaining an ideal calcium concentration in the 
cytoplasm. The majority of cellular calcium is stored in the endoplasmic/ 
sarcoplasmic reticulum (ER/SR) (Gustafsson & Gottlieb, 2008), thus 
mitochondria positioned near calcium release sites on ER/SR are able to capture 
a substantial amount of calcium and to prevent the accumulation of calcium in 
the cytosol (for ref see Gustafsson & Gottlieb, 2008). 
Mitochondrial calcium also interferes with energy metabolism. One good example 
is the activation of dehydrogensases in the mitochondrial matrix, culminating in 
increase of mitochondrial NADH/NAD ratio and leading to an increase of available 
energy for mitochondrial physiological processes. Furthermore, calcium present 
in the matrix has an effect in ATPase, boosting ATP synthesis (Balaban, 2002). 
Two calcium transporters control mitochondrial calcium concentrations. The MCU 
is responsible for the calcium influx and NCX for calcium efflux. The first one, 
works in favor of the electrochemical gradient, while the second works against 
electrochemical gradient (Gunter et al., 2000). However, if calcium concentration 
in the matrix increases beyond a certain level, mitochondrial lose the ability to 
regulate calcium concentration, resulting in calcium overload. This condition can 
lead to the opening of the mPTP (Bernardi & Di Lisa, 2015; Gunter et al., 2000), 
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an event that have been associated with cell death, and justifies the release of 
proapoptotic proteins. 
The mPTP is an IMM channel that is thought to be voltage and calcium 
dependent, cyclosporine A sensitive and conductance channel (for ref see 
Bernardi & Di Lisa, 2015). Besides mitochondria calcium overload, mPTP 
opening is facilitated through oxidative stress, mitochondrial depolarization, 
increased in phosphate concentrations and adenine nucleotide depletion 
(Bernardi et al., 2006; Rasola & Bernardi, 2011). When IMM loses its permeability 
(transitory permeability), allows the entrance of molecular solutes, including ions 
and cofactors resulting in detrimental effects that include the disruption of 
metabolic and ion gradients and energetic imbalance of ATP/ADP ratio between 
matrix and cytosol. As a consequence, mitochondrial p drops and ATP 
hydrolyses takes place (for ref see Halestrap, 2004; Pereira, 2012). Furthermore, 
mPTP induces membrane depolarization, OXPHOS uncoupling, respiratory 
inhibition due to the loss of both co-factors and cytochrome c, and increased 
oxidative stress. If mPTP remains open, differences in protein concentration 
between cytosol and mitochondrial matrix potentiate the osmotic pressure, 
culminating in IMM expansion known as mitochondrial swelling, which leads to 
OMM disruption (Bernardi et al., 2006; Halestrap, 2004). In a situation where 
OMM gets ruptured, proapoptotic proteins are released, including cytochrome c, 
endonuclease G and apoptosis-inducing factor(AIF), resulting in cell death 
(Rasola & Bernardi, 2011). 
The molecular nature of mPTP has been a matter of study for a long time. The 
multi-component composition, also known as classical model of mPTP, 
suggested that mPTP is formed by sevral proteins, including cyclofiline D (Cyp 
D), ANT and VDAC (Bernardi & Di Lisa, 2015). This suggests that OMM is also 
involved in mPTP structure as VDAC are present in the OMM. The Cyp-D is a 
member of cyclophilins family and has a pivotal role in mPTP regulation. It is 
located in mitochondrial matrix and during mPTP opening induces alterations in 
IMM’s channels, leading to an increase in IMM permeability (Broekemeier et al., 
1989). Studies have demonstrated the existence of an interaction between Cyp-
D and ANT, which can be inhibited by cyclophilin-A (CsA). In fact, CsA is one of 
the most studied mPTP inhibitor, as it is able to connect to Cyp-D (Galat, 1993). 
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However, evidences from some studies with ANT and VDAC knockout rats have 
called into question the truly role of these components in mPTP composition 
(Duchen & Szabadkai, 2010). Kokoszka et al. (2004) observed that mitochondria 
from ANT1 and ANT2 knockout mice still shown mPTP- CsA-sensitive activity, 
although triggered by an increased in calcium concentration. This suggests that 
ANT is not essential for pore formation but play a role in its regulation as mPTP 
opening is influenced by ATP and ADP concentrations (Kokoszka et al., 2004).  
Recently, it has been suggested that F0 subunit from ATP synthase is also 
involved in mPTP opening (Bernardi & Di Lisa, 2015). In fact, several studies 
shown that Cyp-D binds to the F1F0 ATP synthase (for ref see Halestrap, 2014), 
this interaction is known to modulate mPTP formation. However, some questions 
remain to elucidate, which justifies the need for more research in this matter. 
 
2.4.5. Mitochondrial quality control 
Mitochondria are dynamic organelles with plastic proprieties, which means that 
they are capable of modifying their morphology and play important roles in 
maintaining cell survival, cell death and cellular metabolic homeostasis (Ni et al., 
2015). These plastic properties result from a balanced interaction of fusion, 
fission, auto(mito)phagy and mitochondrial biogenesis events, ensuring damaged 
mitochondria get removed and proper organization of the mitochondrial network 
is maintained (Lee et al., 2004). Mitochondrial dynamics is now considered to be 
a pivotal cell biological process as it allows mitochondrial quality control and is 
fundamental for cell functioning, mPTP regulation, apoptotic signaling and, at 
last, for cell survival (Campello & Scorrano, 2010).  
Mitochondria are responsible for cell death, including apoptotic and necrotic cell 
death. For this reason, mitochondria quality needs to be well controlled (Ni et al., 
2015). The regulation of mitochondria quality control by several mechanisms will 
be addressed below with more detail. 
Mitochondria’s fission and fusion events constitute one important quality control 
mechanism. Dysfunctional mitochondria are programmed to lose their fusion 
capacity by inactivating fusion and activating fission machineries. This process 
prevents the damaged mitochondria from incorporating back into the healthy 
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mitochondria (Twig et al., 2008; van der Bliek et al., 2013). Furthermore, fission 
and fusion are able to repair damaged components of the mitochondria. In fact, 
fusion events allow the exchange of portions (material) between healthy 
mitochondria and fission events allow the segregation of damaged mitochondria 
(Twig et al., 2008). Additionally, damaged mitochondria segregated by fission 
could be enveloped by autophagosomes and degraded in the lysosome in a 
process called mitophagy (Chan et al., 2011). A proper balance between fission 
and fusion events is possible due to the expression of various molecules 
responsible for regulating each process (van der Bliek et al., 2013). Although the 
proteins associated with the regulation of fusion and fission events are not fully 
understood, mitochondria fusion is mediated, at least in part, by fusion proteins 
mitofusin 1 (Mfn 1), Mfn 2 and optic atrophy 1 (OPA 1), whereas mitochondria 
fission has been described to be mediated by dynamin- related protein 1 (Drp 1), 
which interacts with four mitochondrial receptor proteins, fission 1 (Fis 1), 
mitochondria fission factor (Mff), mitochondrial dynamics protein of 49 KDa 
(MID49) and MID51 (for ref see Ni et al., 2015). 
For instances, under oxidative stress conditions, along with other harmful events, 
mitochondria can be selected to mitophagy. Therefore, mitochondria-derived 
vesicles (MDV) are formed and damaged mitochondrial portion are expelled 
through fusion of MDV whit lysosomes. Thereafter, within MDV, oxidized 
mitochondrial proteins are degraded (McLelland et al., 2014). Furthermore, 
mitochondrial spheroids can also be formed by damaged mitochondria through 
an alternative pathway for damaged mitochondria removal (Ding et al., 2012). 
It is clear that mitochondria are central executioners of cell death as they release 
pro-cell death molecules and/or release toxic ROS. Therefore, it is absolutely 
necessary to remove damage mitochondria via well controlled processes, such 
as mitophagy, fission and fusion mechanisms or even through damaged 
mitochondria remodeling, forming MDV or mitochondrial spheroids (Ni et al., 
2015). However, these mechanisms are not always balanced and controlled, 
resulting in various dramatic scenarios.  
In a situation of excessive fragmentation, mitochondria suffer harmful alterations, 
including alterations in mitochondrial metabolism, mitochondrial membrane 
potential generation, in the content of complex I, IV and V subunits, excessive 
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DRP1- mediated mitochondrial fission and can trigger apoptotic cell death (Chan, 
2006; Wang et al., 2009). Under certain pathologic conditions, excessive fission 
events and subsequent mitophagy can lead to an increased cell death In fact, 
mitophagy can be highly increased in the myocardium to accomplish a 
deleterious rate of protein removal, which can culminate in the removal of vital 
cellular organelles and proteins, activating other proteolytic systems and inducing 
cell death (for ref see Smuder et al., 2013). In the majority of situations, mitophagy 
is triggered by energy depletion, oxidative stress, accumulation of misfolded 
proteins, mitochondrial depolarization and mPTP opening (Lee et al., 2012). 
Cardiolipin is a phospholipid dimer and an important component of the 
cardiomyocyte IMM. Among several important functions under physiological 
conditions, cardiolipin can also act as an apoptosis inducer. Under mitochondrial 
damage, cardiolipin translocates to the OMM and triggers apoptosis, through the 
release of cytochrome c from the intermembrane space into the cytosol, leading 
to calcium release (Chu et al., 2013). When calcium levels reach a certain 
deleterious level, apoptosis is triggered. Furthermore, besides regulating 
apoptosis, cardiolipin is also responsible for triggering mitophagy, depending on 
its peroxidation status. Peroxidized cardiolipin, present in the OMM, induces cell 
death trough apoptosis, whereas non peroxidized cardiolipin triggers mitophagy, 
protecting the cell from apoptosis (for ref see Ni et al., 2015). 
 
Overall, cardiomyocytes are able to develop defense mechanisms against 
anomalous mitochondria before apoptotic cell death is triggered. Therefore, 
mitochondria have a critical role ensuring proper cardiac muscle function as they 
are able to self regulate and adapt to stressful situations, including obesity, 
modifying their own network structure and metabolism in the attempt to cell 
survival (Rimbaud et al., 2009).  
 
2.5. The cardiac “obese” mitochondria  
The heart is the most energetic demand organ in all body highlighting the 
importance of mitochondria to ensure a proper contractile function. Therefore, 
adequate amounts of ATP must be produced to support such energetic demands 
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(Weiss & Maslov, 2004). The FA, ketone acids and carbohydrates are the main 
substrates of the heart to generate ATP. Under normal conditions, the majority of 
ATP formation in the heart results from OXPHOS, with the remain coming from 
glycolysis (Stanley et al., 2005). 
Optimal cardiac function results from a correspondence between energy 
generation pathways and energy expenditure, accomplished by an adequate 
communication and regulation of the different metabolic pathways (Weiss & 
Maslov, 2004). Mostly, myocardial metabolism regulation is linked to arterial 
glucose substrate concentration, hormone concentration, autonomic status, 
coronary flow, inotropic state and nutritional status of the tissue (Stanley et al., 
1997). On the other hand, obesity is known to deregulate myocardial metabolism. 
Bearing in mind the mechanisms by which myocardial metabolism is regulated 
and those cardiovascular alterations induced by obesity, it is easy to understand 
the relation between them. As an example, the accumulation of adipose tissue in 
the epicardium and consequent lipid toxicity is directly related to alterations in 
substrate preference and utilization towards FA metabolism (Griffin et al., 2015). 
Moreover, the deregulated production of adipocytokines, common in obesity, 
results in inflammation, vascular stiffness, increased blood pressure, over-
stimulation of sympathetic tonus, among others, all leading to myocardial 
metabolism deregulation. The culmination of this metabolic deregulation is 
improper cardiac function and the loss of the heart’s ability to respond to higher 
energetic demanding situations, such as physical activity (Weiss & Maslov, 
2004). 
 
2.5.1. Cardiac energy pathways and sources of acetil-CoA 
Fatty acids are the main substrate for cardiac mitochondrial ATP production. 
Mitochondrial OXOPHOS is fueled with energy from electrons that enter the MRC 
(detailed in sections 2.4 – 2.4.2), provided from NADH and FADH2, (Weiss & 
Maslov, 2004). Therefore, Krebs cycle is one key step for ATP production, as it 
constitutes the central metabolic path for the oxidative metabolism of all nutrients. 
Moreover, it is characterized as a sequence of chemical reactions that produce 
energy through the oxidation of acetyl-CoA. The main sources of acetyl-CoA in 
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the heart are: lipids, thought beta-oxidation; carbohydrates, through glycolysis 
and subsequent pyruvate dehydrogenase (PDH) complex; and ketone bodies 
(Weiss & Maslov, 2004). 
 
2.5.2. Obesity-induced cardiac metabolic inflexibility 
Under obesity conditions, the ability to switch between fatty acid and glucose 
oxidation for energy production in response to alterations in substrate availability 
and energetic demands is impaired. This phenomenon is known as metabolic 
inflexibility and is thought to contribute to the development of cardiovascular 
disease (Crewe et al., 2013). The regulation of the various metabolic pathways 
is done through both the degree of expression of key metabolic proteins, such as 
enzymes and transporters, and complex pathway regulation controlled by 
allosteric regulation of enzymes and substrate/product ratio (Fell & Sauro, 1990). 
The process of substrate regulation is called Randle Cycle. When fatty acids are 
oxidized, an increase in Krebs cycle intermediate, citrate, inhibits 
phosphofructokinase-1 (PFK-1) which is the first intermediator and rate limiting 
step in glycolysis (Mor et al., 2011). PDH is also pivotal for regulating the use of 
glucose in relation to fatty acids use and it is regulated by several isoforms of 
pyruvate dehydrogenase kinase (PDK 1, 2, 3, 4) and phosphatase (PDP1 and 2). 
NADH and acetyl-CoA, both products of fatty acid oxidation, activate PDKs, 
resulting in PDH phosphorylation and inhibition (BOWKER-KINLEY et al., 1998). 
Therefore, when fatty acids are available, the capacity to use glucose is low 
(Crewe et al., 2013; Griffin et al., 2015). For instances, Crewe and coworkers 
(2013) have shown in mice that obesity induces an increase in PDK4 
concentrations and subsequent phosphorylation and inhibition of PDH, 
responsible for reducing the ability of cardiac mitochondria to oxidize glucose. 
Furthermore, the increased production of ROS, common is obesity, also has 
some responsibility in metabolic inflexibility as they are capable of modulate 
metabolism through pos-translational alterations (Griffin et al., 2015). Besides 
mitochondria, peroxisomes also feature a high production of ROS in the context 
of metabolic inflexibility, because of their role in lipid metabolism. The chemical 
reactions of beta-oxidation in peroxisomes are capable of generating H2O2 (for 
ref see Griffin et al., 2015). Bearing in mind that CAT is also found in peroxisomes, 
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Rindler et al. (2013) showed in their study that mice fed with a high fat diet 
increased the expression of CAT in the heart, suggesting that excessive H2O2 
may be implicated in metabolic inflexibility and that both peroxisomes and 
mitochondria cooperatively affect cellular redox state in high fat diet feeding. 
The up-regulated production of adopocytokines common in obesity, is also highly 
related to metabolic inflexibility. Actually, leptin and adiponectin are known to 
regulate cardiomyocyte metabolism by increasing glucose and fatty acid uptake 
and oxidation (Palanivel et al., 2008). Additionally, TNF- and IL-6 appear to 
impair cardiomyocyte metabolism as they inhibit PDH and MRC activity. 
However, over-expression of TNF- in certain cardiac cells promote glucose 
oxidation by down-regulating PDK4 and reducing the expression of peroxissome 
- proliferator-activated receptor coactivater 1 (PGC-1), a transcriptional co-
activator of mitochondrial biogenesis and lipid metabolism genes. Therefore, 
taking into account these contradictory effects on cardiomyocyte metabolism, it 
is not yet clear how adipocytokines contribute to metabolic inflexibility (Griffin et 
al., 2015). 
 
2.5.3. ROS involvement in obese mitochondrial-induced cell death 
As previously mentioned, if oxidative stress is present concomitantly with 
alterations in cytosolic and mitochondrial calcium, the mitochondrial permeability 
transition (mPT) may occur with the rupture of OMM leading to the release of 
several apoptotic initiators usually enclosed in the intermembrane space (Ott et 
al., 2007). 
In obesity, ROS production is amplified. Bearing in mind that obesity is related to 
metabolic inflexibility which signifies that ATP requirement is met by the 
catabolism of free fatty acids via -oxidation, resulting in a higher ATP yield, 
leading to an increase in ROS production during oxidative phosphorylation (Chen 
& Zweier, 2014).  
Among all the consequences of extensive oxidative stress in mitochondria, its 
involvement in apoptosis will be now clarified. As a primary target for the 
damaging effects of ROS, mitochondria directly influence cell viability. Therefore 
dependent on this impact, the cells can either repair the damage or trigger cellular 
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death (apoptosis) (Ligr et al., 1999). The interaction of ROS with diverse 
macromolecules is responsible for inducing damage and subsequent apoptosis. 
Mitochondrial DNA represents a critical cellular target for oxidative damage, as it 
is susceptible to ROS attack due to its proximity to the MRC (Ott et al., 2007). 
Lipid peroxidation also effects pivotal mitochondrial function including oxidative 
phosporylation, IMM barrier properties, mitochondrial membrane potential, 
mitochondrial calcium buffering capacity (Zhang et al., 1990), and ultimately the 
triggering of the mPTP opening, an event profoundly connected to cell death. An 
example of a drastic effect of lipid peroxidation is when oxidatively modified 
cardiolipin losses its affinity for binding to cytchorme c, resulting in accumulation 
of free cytochrome c in the intermembrane space and subsequent released into 
the cytosol which constitutes an apoptotic stimuli (Ott et al., 2007). 
The excessive production of ROS in cardiomyocytes is linked to several 
pathophysiological effects. In fact, the chronic exposure to ROS leads to 
impairment of the excitation-contraction coupling, causing arrhythmias and 
contributing to cardiac remodeling and fibrosis, among others potentially deathly 
cardiac events (Chen & Zweier, 2014). 
 
2.6. Exercise as non-pharmacologic strategy for obesity-induce cardiac 
impairment  
Exercise training is now considered to be a potential non-pharmacologic 
therapeutic strategy against several chronic diseases (Nogueira-Ferreira et al., 
2016). Moreover, physical activity has been associated with the improvement of 
cardiac function (Ferreira et al., 2014). In fact, the beneficial effects of physical 
activity on the cardiovascular system are now well characterized, justifying its use 
as a primary prevention for cardiovascular disease. Over de last few decades, 
studies have support the fact that exercise induces protection against several 
cardiovascular diseases, including acute coronary syndromes, myocardial 
infarction, arrhythmia, myocardial stunning, among others (for ref see Alleman et 
al., 2015).  
Exercise cardio-protective potential results from a multi-factorial set of systematic 
adaptations (morphological/biochemical alterations), such as neural, endocrine 
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and paracrine factors, along with autocrine signaling and adaptations of the heart 
itself. In a physiological context, exercise is considered as a stress stimulus that 
induces responses from the cells to better cope with that stressor event. Besides, 
it has the potential to interact with obesity-associated risk factors for 
cardiovascular complications, including BMI, body weight, WC, abdominal fat, 
blood pressure, TG levels and insulin resistance, among others (for ref see 
Golbidi & Laher, 2012). 
In fact, evidences from animal studies using endurance running training have 
shown that exercise positively modulates at least the expression of 76 proteins 
responsible for lipid and organic metabolic processes, vasculogenesis, muscle 
tissue morphogenesis and tissue regeneration (Ferreira et al., 2015). Actually, 
one of the main characteristics of exercise induced cardiac remodeling is 
hypertrophy as this constitutes mechanical advantages normalizing wall stress, 
decreasing oxygen consumption and increasing work capacity (Frey et al., 2004). 
Besides the enhancement in maximal stoke, exercise is also responsible for the 
increase of left ventricular end-diastolic pressure along with increase in muscle 
mass. This adaptive cardiac hypertrophy is accompanied by angiogenesis and 
changes in fibrilar collagen content and organization (Boluyt et al., 2006). 
Overall, exercise contributes to a better cardiovascular health, counteracting 
obesity-induced cardiovascular complications, as it is able to induce alterations 
in a structural level, but also at a molecular level. Several studies have shown 
that exercise is able to improve vascular endothelial dysfunction counteracting 
atherosclerosis, this could be due to the protective effect that exercise has 
against oxidative stress (Hwang & Kim, 2014). Moreover, regular exercise exerts 
a potent anti-inflammatory action (Sallam & Laher, 2016) in part due to the 
increase in energy expenditure and consequently to the reduction of body fat, 
which ultimately decreases the production of pro-inflammatory adipocytokines 
(Cancello, Henegar, et al., 2005). Besides, exercise also increases the 
expression of PGC-1, an important regulator of mitochondrial biogenesis that 
has been associated to increase in energy expenditure (Sutherland et al., 2009). 
Along with all that was said above, Kawanishi et al. (2010) concluded that in 
obese mice, exercise training inhibited the infiltration of the inflammatory 
phenotype M1 macrophages while favoring the infiltration of a less inflammatory 
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phenotype M2 macrophages, contributing to a minor inflammatory state. Chronic 
exercise is also responsible for inducing the release of adiponectin from the 
adipose tissue (Lemos et al., 2007), which represents an anti-inflammatory 
molecule. However, it is important to understand that different types of exercises, 
differing in terms of intensity, duration and frequency may have different impacts 
at cardiovascular level. Epidemiological and animal studies suggest that 
moderate to high-intensity exercise is best for heart protection (Lee et al., 2000).  
Mitochondrial mediated mechanisms associated with chronic exercise-induced 
cardioprotection will be addressed below. 
 
2.6.1. Chronic exercise and cardiac mitochondria adaptations 
Mitochondria play a pivotal role in cell survival, being dysfunctional cardiac 
mitochondria deeply related to cardiac problems. Since exercise represents 
essential heart mitochondrial stress-induced stimuli, the resultant mitochondrial 
adaptations are one of the most relevant elements of exercise-induced protection 
against cardiovascular impairments (Alleman et al., 2015; Ascensao et al., 2006). 
Despite some of the mechanisms behind this phenomenon remain unclear, some 
are related to morphological and biochemical adaptations, including biogenesis, 
antioxidant production or resistance to cell death pathways (Ascensao, Ferreira 
et al. 2007, Kavazis, Alvarez et al. 2009, Kavazis, McClung et al. 2008). Those 
will be briefly addressed in the following sections 
 
2.6.1.1. Exercise and mitochondrial bioenergetics 
During exercise, as the heart energy expenditure increases, the rate of ATP 
production also increases along with cardiac contractility and some perturbation 
in redox state and in calcium homeostasis. These changes have been associated 
to mitochondrial remodeling induced by chronic exercise, which ultimately 
improve heart resistance to stress-induced stimuli, meaning a more functional 
and efficient heart (Antonio Ascensao et al., 2011). 
Several studies with different approaches revealed exercise-induced alterations 
in mitochondrial bioenergetics, including parameters such as state 3 and state 4, 
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along with Respiratory Control Ratio (RCR- measure of dependence of the 
respiratory rate on oxidative phosphorylation and calculated as state 3/state 4) 
and ADP/O ratio of oxygen consumption in isolated mitochondria (Ascensao et 
al., 2007). Moreover, evidences from studies show that chronic exercise induces 
important metabolic adaptations on mitochondrial phosphorylative system that 
may result in improved ability to oxidize substrates. (for ref see Antonio Ascensao 
et al., 2011). In addition, under deleterious conditions as DOX treatment 
(Marques-Aleixo et al., 2015), diabetes (Lumini et al., 2008), aging (Golbidi et al., 
2014) or high fat diet (Hafstad et al., 2013), heart mitochondria can benefit from 
engagement into a chronic exercise intervention, mitigating the bioenergetics 
impairment coupled by these pathologic conditions.  
Ferreira et al. (2014) held a study in order to unveil the molecular mechanisms 
adjacent to the heat mitochondria beneficial effects of physical activity. They 
conclude that exercise training promoted mitochondria adaptations toward 
carbohydrate metabolism, shifting substrate utilization from fatty acids to glucose 
oxidation, resulting in a higher energetic efficiency and improved cardiac function. 
Therefore, it is possible to suggest that exercise can counteract obesity induced-
metabolic inflexibility. Moreover, heart mitochondria from exercised animals 
showed better MRC activity and capacity, especially in chain complexes IV and 
V (Ferreira et al., 2014; Jiang et al., 2014) features common found to be 
deregulated in obese heart mitochondria. 
 
2.6.1.2. Exercise and mitochondrial biogenesis  
To be able to deal with stressful situations, including obesity, cardiac 
mitochondria should be capable of modifying their own network and structure, 
ensuring proper cardiac muscle function. This phenomenon is known as 
mitochondrial dynamics and it is characterized by balanced fusion and fission 
events (Chan, 2006). During pathologic conditions such as obesity, these two 
events are normally unbalanced in favor of fission reactions, which means that 
mitochondria biogenesis is down-regulated, leading to harmful effects on the 
heart (Liesa et al., 2009). 
35 
Evidences from animal studies have documented the beneficial effects of 
exercise in mitochondrial biogenesis. Tao et al. (2015) conducted a study with 
mice trained with a 3-week swimming protocol that were later submitted to acute 
myocardial infarction. Results showed an adaptive increased in mitochondrial 
biogenesis, justified by an increase of mitochondrial DNA replication along with 
activation of PGC-1 signaling in trained mice. Actually, it is now well established 
that physical activity increases mitochondrial content in muscles and in the heart. 
According to several studies, exercise induces an increase in PGC-1 protein 
expression, which activate nuclear respiratory factors 1 and 2 (NRF1, NRF2) and 
subsequent mitochondrial transcription factor A (Tfam) expression along with key 
mitochondrial enzymes transcription, culminating in mDNA transcription and 
replication (for ref see Jornayvaz & Shulman, 2010). 
Given the pivotal role of mitochondrial dysfunctional in the pathogenesis of 
numerous diseases, including obesity, evidences provided from animal studies 
suggest that exercise counteracted those dysfunctions and contribute to 
mitochondrial biogenesis, which justify the use of exercise as a therapeutic 
strategy against obesity (Vettor et al., 2014; Wang et al., 2015).  
 
2.6.1.3. Exercise and mitochondrial oxidative stress/ antioxidant 
capacity 
Exercise and oxidative stress are linked in a very interesting way. In fact, the 
increased oxygen consumption resultant from higher energy expenditure during 
exercise naturally increases ROS production in heart MRC. This increase in ROS 
production after acute exercise causes undoubtedly changes in cellular redox 
status (LI, 1993), evidenced by alteration in antioxidant systems as well as in 
myocardial oxidative injury markers (Ascensao et al., 2007). However, several 
studies have revealed conflictive results in antioxidant enzymes production after 
intensive exercise, including glutathione S-transferase (GST), GPX, glutathione 
reductase (GR), SOD and CAT, featuring increased, decreased or unchanged 
activity (for ref see Ascensao et al., 2007). 
On the other hand, there is growing evidence indicating that short and long 
duration endurance training have positive effects on gene modulation of some 
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enzymatic and non-enzymatic antioxidant systems (Ascensao et al., 2007). It has 
been suggested that regular physical activity delays the accumulation of ROS-
induced cell damage by increasing the antioxidant protective mechanisms in the 
myocardium. More precisely, studies have shown that exercise-induced 
cardioprotection is related to the increased activity of MnSOD (Ferreira et al., 
2015). Brown et al. (2003) demonstrated that prolonged endurance training 
conferred a cardioprotective effect against infarction in a region of myocardium 
subjected to ischemia and subsequent reperfusion, due to increased protein 
expression of myocardial MnSOD. Furthermore, the reduction in myocardium 
chronic oxidant production has also been studied. Judge et al. (2005) investigated 
the effects of long-term voluntary wheel running in H2O2 production and found a 
reduction in mitochondrial oxidant production. Therefore, the benefits of chronic 
exercise may be not only due to the increased antioxidant enzymatic system but 
also due to the reduction of ROS overproduction. 
As obesity is strongly related to unbalanced ROS production, it is vital the 
understanding of how physical activity may affect oxidative stress in obesity 
(Huang et al., 2015). Besides, obesity also induces a pro-inflammatory state, 
which has also been stated to contribute to oxidative stress. Li & Reid (2000) 
demonstrated that TNF--induced skeletal muscle oxidative stress shown to be 
prevented by antioxidant treatment, which suggests that TNF- may constitute 
an important target in correcting obesity-induced oxidative stress (Huang et al., 
2015). Although the data from Li & Reid (2000) is referent to skeletal muscle, it is 
still relevant to this study as it takes into account the relation between obesity and 
oxidative stress. Additionally, several studies (Bruun et al., 2006; Johnson et al., 
2007) showed that dietary caloric restriction along with aerobic exercise and 
anaerobic exercise promote weight loss, which is associated to improvements in 
oxidative stress as well as in inflammation in obesity. As an example, Oh et al. 
(2013) conducted a 12 weeks of moderate to high-intensity aerobic training study, 
demonstrating a decrease in thiobarbituric acid reactive substances, a well 
known lipid peroxidation byproduct and in body weight in obese individuals. 
Huang et al. (2015) suggested that in obese populations, exercise-induced 
improvements of systematic or skeletal muscle-specific oxidative stress may be 
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the result of intensity and/or duration of the intervention, and the weight loss may 
be necessary in order to modify inflammatory profiles. 
However, there is a need for more studies in order to better understand these 
adaptive mechanisms, including against the previously mentioned cardiac 
oxidative stress-induced by obesity.  
 
2.6.1.4. Exercise and mitochondrial calcium resistance and apoptosis 
As it is already mentioned above, mitochondria play an important role in calcium 
homeostasis, constituting a pivotal role for cell’s health and survival. In case of 
mitochondrial calcium overload, common in several heart pathologies, mPTP 
may occur, resulting in loss of impermeability of the mitochondrial membranes, 
leading to the release of pro-apoptotic proteins, including cytochrome c and AIF, 
among others, and culminating in cell death (for ref see Antonio Ascensao et al., 
2011).  
Although there is still some controversy in this mater, reduced levels of 
mitochondrial-mediated apoptotic cell death markers have been observed in 
trained heart mitochondria, suggesting a more resistant phenotype against 
apoptotic stimuli. In fact, exercise is known to alter mitochondria calcium 
homeostasis, increasing mitochondria capacity to tolerate high calcium levels (for 
ref see Antonio Ascensao et al., 2011). Kowaltowski et al. (2001) proposed that 
the decreased in heart mitochondria ROS production as chronic adaptation to 
exercise may contribute to these protective effect, as increased mitochondrial 
oxidative stress is closely related to susceptibility to mPTP opening. Moreover, 
the increase in calcium retention capacity of heart mitochondria from trained rats 
is coincident with the lower maximal velocity of swelling observed in mitochondria 
of trained hearts (Kavazis et al., 2008; Marcil et al., 2006). Therefore, despite of 
the fact that there is still some controversy it has been accepted that exercise has 
a positive effect in mitochondrial calcium resistance and may help preventing 
apoptosis (Ferreira et al., 2015). 
Accordingly, Golbidi & Laher (2011) proposed a division of beneficial 
mechanisms of exercise in two different categories: mechanisms that decrease 
oxidative stress and mechanisms of cellular repair. Among both, mitochondrial 
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adaptations are considered crucial in exercise-induced cardio-protection, in 
particular, mitochondrial calcium resistance (Kavazis et al., 2009; Kavazis et al., 
2008). 
Pons et al. (2013) held a study in a mouse model of obesity to understand the 
effects of regular exercise against myocardial infarction. Their results showed 
that regular exercise constitutes a powerful cardio-protective strategy. Those 
protective mechanisms involved cardiac mitochondrial adaptations, as it 
increased mitochondrial calcium retention capacity along with a better resistance 
to mPTP opening in obese mice. Therefore, it is accepted that regular exercise 
promotes benefic effects in the heart of obese individuals, more specifically, 
ameliorating mitochondrial calcium resistance and cellular apoptosis prevention, 
which ultimately results in a protective effect against myocardial events. 
 
2.7 Relevance of the present study 
Mitochondrial dysfunction, including MRC uncoupling, increased ROS 
production, metabolic inflexibility related to enzymatic activity dysfunction and 
deficient mitochondrial content and size (mitochondria biogenesis) have been 
closely associated to obesity and sedentary life-style (Johannsen & Ravussin, 
2009). As obesity is one of the most prevalent diseases of the century, according 
to World Health Organization (2015b), affecting billions of people worldwide, 
bringing out high costs, including economic (health care costs and job 
absenteeism) along with social, increasing morbidity and mortality, it is extremely 
import to come out with solutions to counteract this epidemic. Therefore, the 
relation between chronic physical activity and mitochondrial functionality in 
obesity is deeply relevant and worthy of investigation.  
So far, a high number of animal and epidemiologic studies have been performed, 
revealing the benefits of regular physical activity counteracting obesity-induced 
overall cardiovascular complications. Based on evidences of several studies, it is 
suggested that a high-fat diet in both humans and mice is associated to elevated 
beta-oxidation and increased ROS production, among other factors, leading to 
mitochondrial dysfunction and cell damage. In fact, lipid overload in obese 
subjects compromises mitochondrial number, morphology and function 
(Yuzefovych et al., 2012). However, to our knowledge no studies have yet 
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elucidated the results of an interaction between the percentage fat consumption 
and exercise-induced mitochondrial adaptations.  
Therefore, the relevance of the present study is mainly due to the innovator 
thought that different diets with different nutrient impact heart mitochondrial 
function differently and may differently interfere in chronic exercise- induced 
mitochondrial adaptations in this obesity context. The results of the present study 
might contribute to the understanding of whether mitochondrial adaptations to 
voluntary FW (as a preventive and therapheutic strategy against obesity) and to 
endurance Tm training (as a therapeutic strategy to mitigate obesity) may 
counteract the deleterious impact imposed by a high-fat diet. 
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3. Aim of the present study 
 
The general aims of the present dissertation are: 
• To compare the effects of different isocaloric diets (control with 35% energy 
from fat and high-fat with 71% energy from fat) on heart mitochondrial 
bioenergetics; 
• To analyze the effects of voluntary free wheel running (as preventive 
strategy) and endurance treadmill training (as a therapeutic strategy) 
against the mitochondrial deleterious effects induced by a high-fat diet; 
 
We can define as specific objectives of this study the analysis of the adaptations 
induced by both types of exercise on heart mitochondria from HFD treated 
animals on: 
• Mitochondrial respiratory activity, before and after anoxia-reoxygenation; 
• Mitochondrial electrical transmembrane potential; 
• Mitochondrial respiratory chain subunits content; 
• Mitochondrial lipid peroxidation and glutathione redox status. 
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4. Materials and methods  
 
4.1. Animals 
All experimental procedures involving animals were conducted in accordance 
with the European Convention for the Protection of Vertebrate Animal Used for 
Experimental and Other Scientific Purposes (CETS no. 123 of 18 march 1986 
and 2005 revision) and the Commission Recommendation of 18 June 2007 on 
guidelines for the accommodation and care of animals used for experimental and 
other scientific purposes [C (2007) 2525]. The researchers responsible for the 
study are accredited by the Federation of Laboratory Animal Science 
Associations (FELASA) for animal experimentation (class c). The Ethics 
Committee of the Faculty of Sport, University of Porto approved the experimental 
protocol.  
Thirty-six male Sprague-Dawley rats (aged 6 wks old) were obtained from 
Charles River Laboratories (L’Arbresle, France) and randomly divided into six 
groups (n=6 per group): Standard diet sedentary (SD+SED), standard diet 
treadmill endurance training (SD+Tm), standard diet free wheel voluntary 
physical activity (SD+FW), high-fat diet sedentary (HFD+SED), high-fat diet 
treadmill endurance training (HFD +Tm) and high-fat diet free wheel voluntary 
physical activity (HFD +FW). Only male rats were used to avoid hormone-
dependent alterations. During the experimental protocol, animals were housed in 
collective cages (two rats per cage) and maintained in a room at normal 
atmosphere (21–22 ºC; ~50–60% humidity) receiving water ad libitum in 12 h 
light/dark cycles. 
 
4.2. Exercise and Diet protocol 
The animals were fed with a standard (Lieber–DeCarli diet #710027) or with a 
high fat (Lieber–DeCarli diet #712031) liquid diet, different isocaloric diets (1.0 
kcal/ml) purchased from Dyets Inc. (Bethlehem, USA). The standard liquid diet 
contained 35% of energy derived from fat, 18% from protein, and 47% from 
carbohydrates and the a high-fat liquid diet contained 71% of energy derived from 
fat, 11% from carbohydrates, and 18% from protein. The quantification of food 
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consumption was daily obtained from graduated feeding tubes (Dyets Inc.) and 
calculated in accordance with manufactures instructions (1 ml = 1 Kcal). 
The feeding protocol included 1 week of adaptation to the liquid diet, in which the 
standard diet was given to all animals, followed by 17 weeks of standard or high-
fat diet according to the experimental groups (Figure 3). After the diet adaptation 
period, animals assigned to the free wheel voluntary physical groups (SD+FW 
and HFD+FW) were housed in polyethylene cages equipped with a running wheel 
[perimeter=1.05m, Type 304 Stainless steel (2154F0106-1284L0106) Tecniplast, 
Casale Litta, Italy)]. The rats were allowed to exercise by having unlimited daily 
access to the running wheel. Running distance was recorded daily using a digital 
counter ECO 701 from Hengstler (Lancashire, U.K.) between 08.00 and 10.00 h.  
After 8 weeks of diet consumption, the animals assigned to the sedentary groups 
(SD+SED and HFD+SED) remained sedentary, while the animals from treadmill 
endurance training groups (SD+Tm and HFD+Tm) were adapted to a LE8700 
motor driven treadmill (Panlab, Harvard, USA) for 5 days at 15 m/min and 0% 
grade with daily increases until 30 min running was achieved. Habituation was 
followed by 8 weeks of endurance exercise performed 5 days/week (Monday–
Friday), in the morning (between 10:00 and 12:00 AM), 60 min/day at a starting 
velocity of 15 m/min that was gradually increased over the training program until 
25 m/min. Sedentary animals (SD+SED and HFD+SED) were placed on a non-
moving treadmill 5 days/week for 60 min in order to expose the animals to the 
same environmental conditions without promoting any physical training 
adaptations. 
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Figure 3. Diagram summarizing the design of diet and exercise protocol (adapted from 
Goncalves et al., 2014) 
 
4.3. Animal euthanasia and heart extraction 
Forty-eight hours after the last Tm exercise session, non-fasted rats were 
anaesthetized (Ketamine 90 mg/kg and Xylazine 10 mg/kg) between 9:00 and 
10:00 AM to eliminate possible effects due to diurnal variation. Thereafter, the 
abdominal and chest cavity were opened, the organs were then perfused with 
NaCl 0.9% and the heart was rapidly excised, rinsed, carefully dried and weighed. 
Mesenteric fat deposit was excised from gastrointestinal tract nearby (from the 
gastroesophageal sphincter to the end of the rectum), carefully dryed and weight. 
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4.4. Blood sampling and anatomical measurements 
At 9 weeks of diet treatment, blood was collected from the tail of all animals, 
centrifuged (3000 rpm, for 10 min at 4 ˚C) and plasma was stored at -80 ˚C for 
later biochemical analysis. At the end of protocol (17 weeks) blood was collected 
once more but directly from the heart, centrifuged (3000 rpm, for 10 min at 4 ˚C) 
and the plasma was stored at -80 ˚C. 
The Adiposity Index (AI) was calculated as a ratio between the sum of all visceral 
adipose tissue deposits and total body weight, multiplied by 100 (Novelli et al., 
2007). 
 
4.5. Isolation of heart mitochondria 
Heart mitochondria were isolated using conventional methods of differential 
centrifugation (Bhattacharya et al., 1991). Briefly, the heart was washed and 
minced in an ice-cold isolation medium containing 250 mM sucrose, 0.5 mM 
EGTA, 10 mM HEPES (pH 7.4) and 0.1% defatted bovine serum albumin (BSA, 
Sigma, cat. no. A7030). The minced blood-free tissue was then resuspended in 
40 mL of isolation medium containing 0.75 mg/mL protease Subtilisin A Type III 
(Sigma P5380) and homogenized with a tightly fitted “Potter-Elvejhem” glass 
homogenizer. The suspension was incubated for 1 min (4°C) and re-
homogenized. The homogenate was then centrifuged at 13000 xg for 10 min, the 
resulting supernatants were decanted and the pellet, essentially free of protease, 
was gently re-suspended with a loose-fitting homogenizer. The suspension was 
centrifuged at 750 xg for 10 min and the resulting supernatant was centrifuged at 
12000 xg for 10 min. The pellet was re-suspended in washing medium and 
centrifuged at 1200 xg for 10 min. The pellet was gently ressuspended to obtain 
the final mitochondrial suspension. EGTA and defatted BSA were omitted on the 
final washing medium. All the procedures were performed within at 4 °C. 
Mitochondrial protein content was determined by the Biuret method using bovine 
serum albumin as standard (AG et al., 1949). 
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4.6. Mitochondrial respiratory activity and anoxia-reoxygenation 
procedure 
Mitochondrial respiratory function was measured polarographically at 30ºC using 
a Biological Oxygen Monitor System (Hansatech Instruments, Norfolk, UK) and 
a Clark type oxygen electrode (Hansatech DW1, Norfolk, UK). Reactions were 
conducted in a 0.75 mL closed, thermostatted and magnetically stirred glass 
chamber containing 0.5 mg/mL of heart mitochondrial protein in a respiration 
buffer (50 mM KCl, 130 mM sucrose, 2.5 mM KH2PO4, and 0.5 mM HEPES, pH 
7.4). 
After 1 min equilibration period, mitochondrial respiration was initiated by adding 
glutamate/malate (G/M) to a final concentration of 5 and 2.5 mM, respectively. 
State 3 respiration was determined after adding ADP (150 nmol); state 4 was 
measured as the rate of oxygen consumption after ADP phosphorylation. 
Thereafter, anoxia was induced by adding an ADP pulse (1250 nmol). The anoxia 
period (1 min) was followed by 4 min of reoxygenation by exposing the 
mitochondria medium to the air (open chamber). After this period, the 
polarographic chamber was closed again and respiratory rates were measured 
once more (states 2, 3 and 4) through the addition of another ADP pulse (150 
nmol/mg) (Figure 4). The respiratory control ratio (RCR) was calculated as the 
ratio between state 3/state 4, while the ADP/Owas calculated as the number of 
nmol ADP phosphorylated by natom O2 consumed (Estabrook, 1967). 
Mitochondrial suspensions were collected and frozen (-80ºC) for lipid 
peroxidation measurements after anoxia-reoxygenation.  
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Figure 4. Typical polarographic oxygen traces obtain in Anoxia-reoxygenation model. 
(adapted from Ascensao et al., 2006) 
 
4.7. Mitochondrial transmembrane electrical potential 
Mitochondrial transmembrane electrical potential () was monitored indirectly 
based on the activity of the lipophilic cation tetraphenylphosphonium (TPP+) 
using a TPP+ selective electrode prepared in our laboratory as previously 
described by A. Ascensao et al. (2011) and according to Kamo et al. (1979). No 
correction for the passive binding of TPP+ to mitochondrial membranes was 
performed, since the purpose of this study was to show relative and not absolute 
 values. As a consequence, a slight overestimation of the  values is 
anticipated. The  was estimated from the following equation (at 30°C):  = 
59 × log (v/V) − 59 × log (10 E/59 − 1), where v, V, and E stand for 
mitochondrial volume, incubation medium volume, and deflection of the electrode 
potential from the baseline, respectively. 
Mitochondrial transmembrane electric potential were carried out at 30 ºC in 1 mL 
of heart reaction buffer (50 mM KCl, 130 mM sucrose, 2.5 mM KH2PO4, and 0.5 
mM HEPESpH 7.4), supplemented with 3 µM TPP+ and 0.5 mg/mL (heart) of 
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mitochondrial protein. For the measurements of  with complex I-linked 
substrates, energization was carried out with G/M (5 mM and 2.5 mM, 
respectively) and ADP (150 nmol) was used to produce a phosphorylation cycle. 
The lag phase, which reflects the time needed to phosphorylate the added ADP, 
was also measured during the experiments. Mitochondrial suspensions were 
collected and frozen (-80ºC) for lipid peroxidation measurements.  
 
4.8. Western-Blotting  
Heart mitochondria protein content was semi-quantified by western blotting. 
Samples were denatured in a lysis buffer and separated by dodecyl sulphate-
polyacrylamide gel electrophoresis (SDS/PAGE) as described by Laemmli 
(1970). This procedure was followed by the transfer of proteins to a PVDF 
membrane (GE Healthcare, RPN303F) according to (Locke et al., 1990). After 
blotting, membranes were blocked with 5% (w/v) of non-fat dried milk or BSA in 
Tris-buffered saline with tween 20 (TBS-T). Membranes were then incubated with 
anti-ANT2/3 (1:100 dilution, goat polyclonal, Santa Cruz Sc-70205), OXPHOS 
antibody cocktail (1:1000 dilution, mouse monoclonal, MitoSciences/Abcam 
MS604). Primary antibodies were diluted in TBS-T containing 2% (w/v) of non-fat 
dried milk or BSA according to the manufacturer instructions. After the incubation 
period, membranes were washed for three times with TBS-T and incubated for 1 
h with horseradish peroxidaseconjugated anti-mouse or anti-goat (1:5000 
dilution, Santa Cruz Sc2005 or Sc2354). Imunoreactive bands were visualized 
using ECL chemiluminescence reagents (GE Healthcare, Amersham RPN2232) 
and acquired by Chemidoc™-XRS image system (BioRad). Images were 
analyzed with Image Lab™ software 4.0 (BioRad). The Ponceau S staining was 
used to correct differences in protein loading or transfer, and the final data was 
expressed as the percentage variation of the control values (%SD+SED).  
 
4.9. Lipid peroxidation 
Before analysis, heart mitochondrial membranes of isolated mitochondrial 
fractions were disrupted by a combination of freeze–thawing cycles to allow free 
access to substrates. The extent of lipid peroxidation in heart, mitochondria was 
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determined by measuring MDA contents through a colorimetric assay, according 
to a modified procedure described previously (Buege & Aust, 1978). Suspended 
mitochondria (2 mg/mL) were centrifuged at 12000 xg for 10 min and re-
suspended in 150 µL of a medium containing 175 mM KCl and 10 mM Tris-HCl, 
pH 7.4. Subsequently, mitochondria from the six groups were mixed with 2 
volumes of trichloroacetic acid (10 %) and 2 volumes of thiobarbituric acid (1 %). 
The mixtures were heated at 90 ºC for 10 min, cooled in ice for 10 min before 
centrifugation (4000 xg for 10 min, 4 ºC). The supernatants were collected and 
the absorbance measured at 535 nm. The amount of MDA content formed was 
expressed as nanomoles of MDA per milligram of protein (	535=1.56 x 10−5 M−1 
cm−1). 
 
4.10. Gluthatione quantification 
Glutathione activity in the heart was measured using Tietze (1969) modified 
method. For the samples preparation it was adding equal volume of perchloric 
acid (PCA) 10% to the homogenized samples and centrifuged at 13000 rpm for 
2 min at 4 ºC. The resulting supernatants were used for the total glutathione and 
oxidized gluthatione assays.  
For the determinations of total gluthatione (GS), the samples, previously 
prepared were neutralized with potassium bicarbonate, centrifuged (1300 rpm 
during 1 min at 4ºC) and supernatants transferred into a 96-well microplate. 
Proper blanks were achieved for each experiment, receiving the same treatment 
as samples. The next step is the incubation with NADPH solution in the 
microplate reader (15 min at 30 ºC). Finally glutathione reductase was added and 
the reaction kinetics was read in the microplate reader at 405 nm for 3 min. 
For the determination of oxidize gluthatione (GSSG), the samples previously 
prepared were incubated for 1h at 4ºC with 2-vinilprinidine and neutralized with 
potassium bicarbonate. The samples were centrifuged (1300 rpm during 1 min at 
4ºC) and supernatants transferred into a 96-well microplate. Proper blanks were 
achieved for each experiment, receiving the same treatment as samples. 
Sulphydil reagent 5,52-dithio-bis (2-nitrobenzoic acid) (DTNB) was added, 
followed by 15 min at 30ºC incubation period. Finally, glutathione reductase was 
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added and the reaction kinetics was read in the microplate reader at 405 nm for 
3 min. GSH content was calculated by subtracting the double of GSSG from total 
GS content. Glutathione ratio was calculated by dividing GSH by GSSG. Protein 
content from heart homogenates were spectrophotometrically determined by 
using the Bradford method using bovine serum albumin as standard (Bradford, 
1976). 
 
  
 
 
 
 
 
 
 
 
53 
5. Results 
5.1. Food consumption and exercise interventions 
Figure 5A represents the food consumption from all six groups since the 
beginning of the protocol (week 1) until the end of the protocol (week 17). The 
running distance on the Tm, during 8 weeks (HFD+Tm, SD+Tm) and on the FW, 
from the beginning to the end of the protocol (HFD+FW, SD+FW) is presented in 
Figure 5B. No differences were found in energy intake, free wheel running and 
treadmill running distances between groups. These data are valuable to better 
analyze and understand the majority of the results.  
 
 
Figure 5. Food consumption (A), running distance in treadmill (Tm) and free wheel (FW) 
per day (B). Data are Mean ± SEM (n =10). Significant (p < 0.05) main effect of diet 
treatment (DT), exercise treatment (ET) and their interaction (DT x ET) or the absence 
of differences (NS) is shown” (adapted from Goncalves et al., 2015) 

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5.2. Animal characterization 
Body weight, mesenteric fat, absolute and relative heart weights, heart 
mitochondrial protein yielding of all animal groups were measured and are shown 
in table 3. 
After 17 weeks of HFD treatment, sedentary animals featured a significant 
increase in mesenteric fat and in Adiposity Index (AI) compared to SD 
counterparts, whereas, no differences were found in body weight and heart-to-
body weight ratio between sedentary HFD and SD. Both types of physical activity 
successfully diminished mesenteric fat and AI not only in SD but also in HFD 
treated animals (SD+FW and SD+Tm vs. SD+SED; HFD+FW and HFD+Tm vs. 
HFD+SED). In SD treated animals, both exercise regimens induced decrease in 
body weight compared to their sedentary counterparts (SD+FW and SD+Tm vs. 
SD+SED); however, in HFD treated animals only Tm training was able to 
decrease body weight compared with Sedentary and FW running (HFD+Tm vs. 
HFD+SED and HFD+FW). Exercised animals fed with a SD showed a lower body 
weight than the respective groups fed with a HFD (SD+FW vs. HFD+FW and 
SD+Tm vs. HFD+Tm).  
Although we did not find differences in heart weight among the different studied 
groups, it is possible to observe that both exercise modes increased heart-to-
body weight ratio in SD treated animals (SD+Tm and SD+FW vs SD+SED). In 
HFD fed mice, only endurance Tm running intervention was able to induce heart 
hypertrophy (HFD+Tm vs. HFD+SED). Additionally, independently of the diet 
treatment, animals submitted to the Tm training showed an increased heart-to-
body weight ratio compared with their FW counterparts (SD+Tm vs. SD+FW; 
HFD+Tm vs. HFD+FW). No significant differences were found in mitochondrial 
yielding neither in isolated mitochondrial protein. 
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Table 3. Anatomic characterization of animals 
 SD+SED SD+FW SD+Tm HFD+SED HFD+FW HFD+Tm pd 
Body weight (g) 676.8+11.5 612.7+15.3a 559.3+10.0a,b 684.3+14.2 710.0+10.8b 592.8+7.3A,B,c. DT×ET  
Heart weight (g) 1.8+0.00 1.9+0.1 1.9+0.1 1.8+0.0 1.8+0.1 1.9+0.0 NS 
Heart / body weight (mg g-1) 30.0+0.1 32.0+0.2a 36.0+0.1a,b 26.0+0.1 28.0+0.1b 32.0+0.1A,c ET 
Mitochondrial protein (mgml-1) 25.8+2.1 27.1+1.2 28.2+2.6 30.8+1.2 33.7+1.6 28.7+1.9 NS 
Heart mitochondrial isolation yield 
(mg protein/g tissue) 15.5+1.3 14.1+0.9
 14.4+0.7 17.5+0.8 19.1+1.6 15.1+1.1 DT 
Mesenteric fat (g) 10.4±0.3 7.8±0.8a 3.6±0.6a,b 15.7±0.8a 11.7±0.8A,b 5.5±0.2A,B,c DTxET 
Adiposity Index % 9.0±0.2 7.5±0.5a 4,8±0.5a,b 10.8±0.4a 8,9±0.4A,b 6,8±0.1A,B,c DT,ET 
Data are means ± SEM, (n=10). Different letters (symbols) indicates significant differences between groups: SD+SED – standard diet sedentary; SD+FW – 
standard diet free wheel running; SD+Tm – standard diet treadmill running (endurance training); HFD+SED – high fat diet sedentary; HFD+FW – high fat diet 
free wheel running; HFD+Tm – high fat diet treadmill running (endurance training). (p<0.05) (adapted from Goncalves et al., 2015). 
a
 vs. SD+SED; A vs. HFD+SED; b vs. SD+FW; B vs. HFD+FW, c vs. STm d Significant (p<0.05) main effect of diet treatment (DT), exercise treatment (ET) and 
their interaction (DT×ET) or the absence of differences (NS) is shown. 
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As it is presented in Table 4, no relevant differences were found between Tm and 
SED groups at 9 week in the analyzed blood parameters (SD+SED vs. SD+Tm 
and HFD+SED vs. HFD+Tm). After 9 weeks of HFD treatment, sedentary animals 
showed a higher content of cholesterol and HDL and a lower content of VLDL 
and triglycerides, compared to SD treated animals (SD+SED vs. HFD+SED). FW 
exercise influenced the content of triglycerides and cholesterol in SD animals 
(SD+FW vs SD+SED) and in cholesterol and VLDL in HFD animals (HFD+FW 
vs. HFD+SED), when compared to their SED counterparts.  
Blood analysis after 17 weeks of HFD sedentary animals showed increased HDL 
and decreased VLDL and triglycerides plasma levels (SD+SED vs. HFD+SED). 
Both exercise regimens decreased triglycerides plasma levels in SD treated 
animals (SD+FW and SD+Tm vs. SD+SED) and only Tm running was able to 
decrease cholesterol levels (SD+Tm vs. SD+SED). Exercise did not influenced 
blood parameters in HFD groups (HFD+FW and HFD+Tm vs. HFD+SED). In SD, 
Tm running animals featured high levels of triglycerides and VLDL than the FW 
running animals (SD+Tm vs. SD+FW), whereas in HFD, FW group presented an 
increased cholesterol levels than theirs Tm counterparts (HFD+FW vs. 
HFD+Tm). 
 
57 
Table 4. Blood analysis after 9 and 17 weeks of treatments 
 Timing SD+SED SD+FW SD+Tm HFD+SED HFD+FW HFD+Tm pd 
Glucose (g/L) 
9 week 113.00±1.81 106.00±4.45 111.20±2.06 118.20±2.65 125.25±0.91b 119.10±2.31c DTxET 
17week 228.00±18.68 217.00±15.59 246.20±12.79 248.30±6.90 235.00±12.51 212.10±21.27 NS 
Triglycerides(g/L) 
9 week 41.40±1.65 30.00±1.47a 41.20±0.91b 27.20±1.14a 29.00±1.27 26.43±1.41c DTxET 
17 week 106.50±15.58 57.50±5.55a 67.50±9.30a,b 30.75±2.55a 40.20±6.99 22.86±2.73c DTxET 
Cholesterol (g/L) 
9 week 60.50±2.65 47.67±2.39a 60.34±3.11b 78.75±2.41a 65.51±2.07A,b 76.90±2.21B,c DT,ET 
17 week 69.00±2.41 58.33±2.46 51.40±3.14a 77.51±4.14 88.80±8.51b 72.66±3.93c,B DT,ET 
HDL (g/L) 
9 week 36.60±1.28 32.45±0.49 37.00±1.52 52.00±1.29a 49.76±2.73b 51.86±1.10c DT 
17 week 35.00±2.05 38.72±2.05 34.36±1.02 55.50±3.00a 59.20±4.76b 48.41±2.51c DT 
VLDL (g/L) 
9 week 8.28±0.33 7.45±0.32 9.76±0.86b 5.44±0.23a 8.35±0.21A 6.14±0.55B,c DTxET 
17 week 17.28±1.78 13.13±0.51 19.07±0.84b 6.15±0.51a 8.04±1.40b 4.57±0.55c DT 
Data are means ± SEM, (n=10). Different letters indicates significant differences between groups: SD+SED – standard diet sedentary; SD+FW – standard diet 
free wheel running; SD+Tm – standard diet treadmill running (endurance training); HFD+SED – high fat diet sedentary; HFD+FW – high fat diet free wheel 
running; HFD+Tm – high fat diet treadmill running (endurance training). (p<0.05). HDL, high-density lipoprotein; VLDL, very low-density lipoprotein (adapted 
from Goncalves et al., 2015)  
a
 vs. SD+SED; A vs. HFD+SED; b vs. SD+FW; B vs. HFD+FW, c vs. STm d Significant (p<0.05) main effect of diet treatment (DT), exercise treatment (ET) and 
their interaction (DT×ET) or the absence of differences (NS) is shown 
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5.3 Heart mitochondria oxygen consumption and transmembrane 
electric potential 
Mitochondrial oxygen consumption and  were measured to identify exercise 
and diet-dependent effects. The results are shown in Figure 6 and Figure 7. 
No differences were found between diet treatment in mitochondria oxygen 
consumption neither in transmembrane electric potential parameters (SD+SED 
vs. HFD+ SED). In both diet treatments, Tm running significantly increased the 
coupling between oxygen consumption and ADP phosphorylation (RCR) 
compared to their SED counterparts (Figure.6C; SD+Tm vs. SD+SED, HFD+Tm 
vs. HFD+SED). Moreover, in SD treated animals Tm running significantly 
decreased heart mitochondrial respiratory rate in state 4 and increased RCR 
value when compared to FW animals (Figure 6B and 6C; SD+Tm vs. SD+FW). 
No significant differences were found between groups in state 3 mitochondrial 
respiratory rate neither in ration between ADP phosphorylated and oxygen 
consumption (ADP/O ratio). 
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Figure 6. Effect of diet and exercise treatments on heart mitochondrial oxygen 
consumption (A) state 3 of mitochondrial respiration, (B) state 4 of mitochondrial 
respiration, (C) RCR, and (D) ADP/O. Data are means ± SEM obtained from different 
mitochondrial preparations (0.5 mg/mL protein) for each group. Respiration was 
measured with G/M as substrates. RCR, respiratory control ratio (state 3/state 4); 
ADP/O, number of nmol ADP phosphorylated by natom of oxygen consumed. SD + SED 
—standard diet sedentary, SD +FW — standard diet free wheel, SD+Tm — standard 
diet treadmill, HFD+SED — high fat diet sedentary, HFD+FW — high fat diet free wheel, 
and HFD +Tm— high fat diet treadmill, n=10 per group. *SD+TM or SD+FW vs. SD+SED 
and HFD+TM or HFD+FW vs. HFD+SED (p 
 0.05); SD+Tm vs. SD+FW or HFD+Tm 
vs. HFD+FW (p 
 0.05). Significant (p 
 0.05) effects of exercise treatment (E), diet 
treatment (D), exercise treatment and diet treatment (E, D) or their interaction (E x D) 
are indicated. Non Significant (NS), p > 0,05. 
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As seen in Figure 7, no significant differences were found between diet treatment 
and exercise treatment in maximal energization (), ADP- induced 
depolarization (), ADP-induced repolarization () and in ADP lag- phase.  
 
 
 
Figure 7. Effect of diet and exercise treatments on heart mitochondria  fluctuations 
(A) maximal energization, (B) ADP-induced depolarization, (C) ADP-induced 
repolarization and (D) ADP phosphorylation lag phase. Data are means ± SEM obtained 
from different mitochondrial preparations (0.5 mg/mL protein) for each group.  
developed was measured with G/M as substrates. Lag phase, time elapsed in the 
depolarization/repolarization cycle during ADP phosphorylation. SD + SED —standard 
diet sedentary, SD +FW — standard diet free wheel, SD+Tm — standard diet treadmill, 
HFD+SED — high fat diet sedentary, HFD+FW — high fat diet free wheel, and HFD 
+Tm— high fat diet treadmill, n=10 per group. Significant (p 
 0.05) effects of exercise 
treatment (E), diet treatment (D), exercise treatment and diet treatment (E, D) or their 
interaction (E x D) are indicated. Non Significant (NS), p >0,05. 
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5.4 Heart mitochondrial oxygen consumption in Anoxia-Reoxygenation 
The results of heart mitochondrial oxygen consumption obtained after the in vitro 
anoxia-reoxygenation (A-R) experiments are shown in Figure 8. Oxygen 
consumption rates (state 3 and state 4), RCR and ADP/O were calculated in post-
reoxygentaion conditions. As seen in Figure 8, no statistically differences were 
found between diets (SD+SED vs. HFD+SED). In SD treated groups, Tm running 
significantly decreased heart mitochondrial state 4 respiratory rate and increased 
ADP/O after A-R (Figure 8B and 8D; SD+Tm vs. SD+SED). In HFD treated 
animals, Tm running significantly increased RCR (Figure.8C; HFD+Tm vs. 
HFD+SED). No significant differences were found between exercise groups from 
each diet. Neither exercise nor diet produced any effect on state 3. 
Despite the differences found, is important to note that all oxygen consumption 
parameters before and after exposed heart mitochondria fractions to the 
deleterious anoxia-reoxygenation stimuli were significantly compromised 
independently of the diet treatment or exercise engagement (data non showed). 
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Figure 8. Effect of diet and exercise treatments on heart mitochondria after Anoxia-
Reoxygenation stimulation (A) state 3 of mitochondrial respiration, (B) state 4 of 
mitochondrial respiration, (C) RCR, and (D) ADP/O. Data are means ± SEM obtained 
from different mitochondrial preparations (0.5 mg/mL protein) for each group. Respiration 
was measured with G/M as substrates. RCR, respiratory control ratio (state 3/state 4); 
ADP/O, number of nmol ADP phosphorylated by natom of oxygen consumed. SD + SED 
—standard diet sedentary, SD+FW — standard diet free wheel, SD+Tm — standard diet 
treadmill, HFD+SED — high fat diet sedentary, HFD+FW — high fat diet free wheel, and 
HFD +Tm— high fat diet treadmill, n=10 per group. *SD+TM or SD+FW vs. SD+SED 
and HFD+TM or HFD+FW vs. HFD+SED (p 
 0.05). Significant (p 
 0.05) effects of 
exercise treatment (E), diet treatment (D), exercise treatment and diet treatment (E, D) 
or their interaction (E x D) are indicated. Non Significant (NS), p > 0,05. 
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5.5 OXPHOS protein semi- quantification 
The effects of diet and/or exercise on OXPHOS levels were evaluated by Western 
Blotting. As seen in Figure 9, no differences were found between diet treatments 
in complex I, II and IV content; however, HFD treatment significantly decreased 
complex V content compared to SD treated animals (Figure 9D; SD+SED vs. 
HFD+SED). In SD treated animals, FW running significantly increased complex 
IV and complex V content when compared to their SED and Tm counterparts 
(Figure 9C and 9D; SD+FW vs SD+SED and SD+Tm). Interestingly, also in SD, 
Tm running animals showed a significantly decrease in complex V content 
compared to their SED counterparts (Figure 9D; SD+Tm vs. SD+SED). 
In HFD treatment, both Tm and FW were able to significantly increase complex 
IV and complex V content (HFD+Tm and HFD+FW vs. HFD+SED). In HFD 
treatment, FW running significantly increased complex V content when compared 
to their Tm counterparts (Figure 9D; HFD+FW vs. HFD+Tm). Additionally, Tm 
running induced higher values of complex IV and complex V in HFD animals 
when compared to SD counterparts (Figure 9C and 9D; HFD+Tm vs. SD+Tm). 
No effects of exercise or diet were found in complex I and in complex II content.  
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Figure 9. Effect of exercise and diet treatment on heart mitochondria's respiratory 
complexes (OXPHOS): (A) Complex I; (B) Complex II; (C) Complex IV; (D) Complex V; 
(E) Protein loading control by Ponseau-S staining; (F) ) Typical immunoblots. Data are 
mean ± SEM. SD + SED —standard diet sedentary, SD +FW — standard diet free wheel, 
SD+Tm — standard diet treadmill, HFD+SED — high fat diet sedentary, HFD+FW — 
high fat diet free wheel, and HFD +Tm— high fat diet treadmill, n=8 per group. *SD+TM 
or SD+FW vs. SD+SED and HFD+TM or HFD+FW vs. HFD+SED (p 
 0.05); SD+Tm 
vs. SD+FW or HFD+Tm vs. HFD+FW (p 
 0.05); SD+SED vs. HFD+SED or SD+FW 
vs. HFD+FW or SD+Tm vs HFD+Tm (p
0.05). Significant (p 
 0.05) effects of exercise 
treatment (E), diet treatment (D), exercise treatment and diet treatment (E, D) or their 
interaction (E x D) are indicated. Non Significant (NS), p >0,05. 
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5.3 Glutathione and lipid peroxidation measurements 
Mitochondrial lipid peroxide was measured to identify whether exercise and diet 
treatments modulate mitochondrial oxidative stress marker before and after A-R. 
As seen in Figure 10, no differences were found between diet treatments 
(SD+SED vs. HFD+SED). Only MDA level were significantly higher in HFD 
treated animals engaged to Tm running compared to their SD counterparts 
(Figure 10A; HFD+Tm vs. SD+Tm). This difference was not found after A-R. No 
other differences were found between exercise regiments and diets in MDA levels 
and neither in MDA levels of A-R. Despite the differences found, is important to 
note that MDA content before and after exposed heart mitochondria fractions to 
the deleterious anoxia-reoxygenation stimulus was significantly increased 
independently of the diet treatment or exercise engagement (data non showed). 
 
 
Figure 10. Effect of exercise and diet treatment on heart mitochondria's (A) MDA content 
and (B) MDA content in Anoxia-Reoxygenation. Data are means ± SEM obtained from 
different mitochondrial preparations (2 mg/mL protein) for each group. Data are mean ± 
SEM. SD + SED —standard diet sedentary, SD +FW — standard diet free wheel, SD+Tm 
— standard diet treadmill, HFD+SED — high fat diet sedentary, HFD+FW — high fat diet 
free wheel, and HFD +Tm— high fat diet treadmill, n=10 per group. HFD+Tm vs.SD+Tm 
or HFD+FW vs. SD+ FW (p 
 0.05). Significant (p 
 0.05) effects of exercise treatment 
(E), diet treatment (D), exercise treatment and diet treatment (E, D) or their interaction 
(E x D) are indicated. Non Significant (NS), p > 0,05. 
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The effects of diet and/or exercise on non-enzymatic antioxidant machinery were 
evaluated by measuring glutathione redox status. As seen in Figure 11, in 
sedentary groups no significant differences were found between diets neither in 
reduced glutathione, in oxidized glutathione levels nor GSH/GSSG ratio 
(SD+SED vs. HFD+SED). No significant differences were found between 
exercise and sedentary groups in SD treatment. In HFD treated animals, FW 
running significantly increased reduced glutathione compared to their Tm 
counterparts (Figure 11A; HFD+FW vs HFD+Tm) and decreased oxidized 
glutathione levels when compared to their SED counterparts (Figure 11B; 
HFD+FW vs. HFD+SED). HFD+FW running significantly increased GSH/GSSG 
ratio when compared to Tm and SED animals (HFD+FW vs. HFD+SED and 
HFD+Tm Figure 11C). 
 
Figure 11. Effect of exercise and diet treatment on heart mitochondria's: (A) Reduced 
Glutathione content (GSH); (B) Oxidized Glutathione content (GSSG) and (C) 
Glutathione Ratio: GSH/GSSG. Data are mean ± SEM. SD + SED —standard diet 
sedentary, SD +FW — standard diet free wheel, SD+Tm — standard diet treadmill, 
HFD+SED — high fat diet sedentary, HFD+FW — high fat diet free wheel, and HFD 
+Tm— high fat diet treadmill, n=10 per group. *SD+TM or SD+FW vs. SD+SED and 
HFD+TM or HFD+FW vs. HFD+SED (p 
 0.05); SD+Tm vs. SD+FW or HFD+Tm vs. 
HFD+FW (p 
 0.05); HFD+Tm vs.SD+Tm or HFD+FW vs. SD+ FW (p 
 0.05). 
Significant (p 
 0.05) effects of exercise treatment (E), diet treatment (D), exercise 
treatment and diet treatment (E, D) or their interaction (E x D) are indicated. Non 
Significant (NS), p >0.05. 
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6. Discussion 
The present study provided support in order to understand the effects of two 
different exercise modalities (voluntary wheel running and endurance treadmill 
training) on mitochondrial function of rats fed with a high-fat diet. 
The study sample was constituted only by male rats, as female rats were 
excluded due of the reported interaction between hormonal state and 
mitochondrial ROS production (Giglia & Bussmann, 2001). For instances, Borrás 
et al. (2003) showed that the expression and activity of various mitochondrial 
antioxidant enzymes, including SODs and GPx is higher in female rats. Two years 
later, Borrás et al. (2005) demonstrated an up regulation of Mn-SOD and GPx 
induced by low doses of oestradiol, supporting the idea of a protecting effect of 
the female hormonal phenotype against oxidative stress. 
 
6.1. Diet Protocol 
As a result of the increasing prevalence of obesity worldwide, along with its 
associated cardiovascular complications, the development of obese animal 
models have been essential to better understand the physiological mechanisms 
behind this epidemic, as well as the most effective strategies to prevent and 
counteract obesity induced-complications. Currently, in obesity research, 
scientists are resorting to obesity animal models, frequently rats. Besides genetic, 
obesity can also be induced by nutritional diets. Sprague-Dawley rats are highly 
sensitive to HFD compared to other common rat strains (Goyal et al., 2012).  
Isocaloric models differ from hypercaloric models because the diet composition 
is the truly obesity inducer (Goyal et al., 2012). The preference for this diet model 
in obesity research is resultant from scientific evidences showing that not only the 
quantity but also diet composition is responsible for inducing an obese phenotype 
and the consequent obesity constrains (Estrany et al., 2011; Mann, 2002). The 
two most used isocaloric models are HFD or high carbohydrate diets. The present 
study used a HFD supported by evidences that associate this type of diet with an 
imbalance of energy homeostasis, ultimately leading to increases in body fat 
deposition, cardiovascular complications and type 2 diabetes (Grundy, 1999). 
Moreover, obesity and diabetes are frequently associated with nonalcoholic fatty 
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liver diseases, which include nonalcoholic steatohepatitis (NASH). The isocaloric 
diet model used in the present study was developed by Lieber et al. (2004), with 
the purpose of inducing obesity and NASH in animals, a protocol also used by 
others from our group (Goncalves et al., 2015). Since this diet protocol was 
created with the main purpose of inducing NASH, the SD was developed to be a 
control diet for NASH. Moreover, NASH is also related with an increased 
prevalence for developing cardiovascular complications (Bhatia et al., 2012; 
Lautamaki et al., 2006), justifying the use of HFD-induce NASH in the context of 
the present study. 
Generally, independently of the obesity-induced nutritional model, the variety of 
diet protocols is alarming, which leads to some controversial results and makes 
almost impossible the comparison between studies. This methodological issue is 
elegantly presented by Warden & Fisler (2008). In theory, the control diet should 
correspond to a normal/healthy diet of the specie in study. But even if the diet 
protocol is perfectly controlled and adequate it is essential to question whether 
rats and humans have the same physiological responses to dietary changes. In 
fact, Borghjid & Feinman (2012) conducted a study with high-fat, no-carbohydrate 
diet (80% of fat and 0% of CH) in mice. The results showed that experimental 
mice developed fatty heart, abdominal adiposity, metabolic disruption and greater 
weight gain than the isocaloric control diet.  
A healthy diet for human adults is composed by 45% to 65% of energy provided 
from carbohydrates, 20% to 35% of energy provided from fat and 10% to 35% of 
energy provided from protein (Institute of Medicine, 2001). The SD used in the 
present study (Lieber et al., 2004), with 47% of energy provided from 
carbohydrate, 35% of energy provided from fat and 18% of energy provided from 
protein is very similar to a healthy diet for human adults in accordance to the 
Institute of Medicine (2001). However, in accordance to the American Institute of 
Nutrition, a healthy diet for rats is composed by approximately 57% of energy 
provided from carbohydrates, 13% of energy provided from fat and 30% of energy 
provided from protein (Reeves PG et al., 1993). Interestingly, there are several 
studies that use control diets with less fat percentage (Calligaris et al., 2013; Kang 
et al., 2015) in diet-induced obesity studies. Therefore, the composition of healthy 
diets in rodents differs from a normal/healthy human diet, mostly presenting lower 
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fat percentage. As it can be depicted in table 5, the composition of the 
normal/healthy diets that can be purchased in a few companies specialized in 
rodents laboratory diets are different from a healthy human diet.  
Table 5. Percentage of the calories provided by carbohydrates; fat and proteins in some 
typical commercial diets for rodents.  
Company Carbohydrates (%) Fat (%) Protein (%) 
A 72.4 8.4 19.3 
B 62.7 13.1 24.1 
C 75.9 9.4 14.7 
D 48.0 4.0 14.3 
 
Although, as stated before, the SD used in the present study is quite similar to a 
healthy human diet, the unexpected lack of differences between SD and HFD 
namely in heart mitochondrial function evaluated parameters, could by partially 
explained by the differences considering rodents and human healthy diets. 
Despite data already published by our group (Goncalves et al., 2014) concerning 
the impact of the different exercise models against NASH related deleterious 
effects perpetrated by the high-fat diet, we could not exclude the hypothesis that 
the SD used in the present protocol had distinct impact in the heart compared to 
liver. Corroborating this assumption, SD induced a mild steathosis in rodents 
(Lieber et al., 2004), which is a condition not seen in humans consuming a similar 
diet (Institute of Medicine, 2001). Other possible explanation could be related with 
the sequence by which organs are affected by obesity, being the present diet 
protocol duration not enough to induce cardiac mitochondrial alterations. This 
hypothesis will be explored with detail below (6.4. The effects of high fat diet on 
cardiac mitochondrial bioenergetics and redox state)  
There are numerous obesity studies, conducted with rodents, compare natural-
ingredient chow (cereal based diet) as a control/healthy diet for rodents with HFD 
diets, despite differences in content of micro and macronutrients, as highlighted 
by Warden & Fisler (2008). Generally, chow is a high-fiber diet, composed by 
complex carbohydrates and fats from vegetable sources; in contrast, defined high 
fat diets are composed by sucrose, soybean oil or lard and supplemented with 
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amino-acids, minerals and vitamins, among others (Warden & Fisler, 2008). 
When comparing chow with a HFD, it is not possible to determinate if the effects 
are resultant from fat percentage or from other dietary components. This 
important methodological question was safeguarded in the present study. We can 
assume that the diet protocol from the present study allows the comparison 
between HFD and SD groups, as both diets have the same composition in terms 
of micro and macronutrients, only deferring in the percentage in which these 
components are conjugated. Moreover, from our knowledge, this is the first study 
that is concerned with the effects of different diet composition, instead calories 
consumed, on cardiac mitochondrial function. 
Although the importance of diet composition is unquestionable, the caloric 
(kcal/g) value of the diet or the caloric value of a daily portion (kcal/day) is 
extremely important and should not be forgotten. In the present study, the rats 
ate between 80kcal to 100kcal daily mean per week (Figure 5) and no differences 
were found between groups. Therefore, it is possible to say that the physiological 
and anatomical changes were entirely a consequence of the diet composition. 
Goncalves et al. (2016) showed that a hypercaloric diet (with a fat percentage of 
36 % different from the regular diet, 3.1%) led to several cardiac changes, 
including myocardial structural and functional remodeling, cardiomyocyte 
stiffening and fibrosis. The protocol in the previous study used a regular diet with 
0.0029 Kcal/mg and a hypercaloric diet with 0.0054 Kcal/mg. However, due to 
the methodological differences between this study and the present one, we still 
have to question if the amount of calories consumed per day by the rats of the 
present study corresponds to a normocaloric diet or to hypercaloric diets to 
rodents. 
 
6.2. Exercise Protocol 
The exercise protocol used in the present study was designed to ascertain the 
possible preventive and therapeutic effects of two different types of physical 
activity on heart mitochondrial function in a diet-induced obesity model. Firstly, it 
is essential to clarify the main purpose of each studied exercise model. As in 
voluntary (FW) run, animals started exercising at the beginning of the diet 
protocol and sustain this physical activity model throughout the protocol, the 
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discussion of the results should highlight the potential preventive and therapeutic 
feature of FW against diet-induced mitochondrial cardiac complications. In 
contrast, the endurance (Tm) trained animals started exercising after 8 weeks of 
diet consumption, therefore, in this case, the purpose is to analyze the therapeutic 
ability of endurance training against obesity-induced cardiac mitochondrial 
dysfunction. This set up was already used in other studies (Goncalves et al., 
2015; Passos et al., 2015). 
Nowadays, the public health recommendations for moderate and vigorous 
physical activity have been established, supporting the link between physical 
activity and health (Bouchard, 2001; Katzmarzyk, 2010; Physical Activity 
Guidelines Advisory Comitee Report, 2008), including its preventive potential 
against cardiovascular (Alleman et al., 2015; Ascensao et al., 2007), metabolic 
(Goncalves et al., 2015; Hwang & Kim, 2014), mental (Farina et al., 2014), among 
others diseases. In accordance, an elegant review by Pedersen and Saltin 
(Pedersen & Saltin, 2015) provided evidence-based for prescribing exercise as a 
therapeutic non-pharmacological strategy against 26 different diseases, including 
metabolic and cardiovascular. Moreover, the American College of Sports 
Medicine statement position suggest that 30 minutes of moderate-intensity 
physical activity, 5 days per week, or more intense exercise for less time (20 
minutes, 3 days per week) are recommended (Garber et al., 2011). Unfortunately, 
this does not seem to be accomplished by the majority of the population (for ref 
see Katzmarzyk, 2010).  
Epidemiological studies suggest that the amount of sitting time during work time, 
school time, watching television or associated with other sedentary activities may 
constitute an independent risk factor for deleterious cardiovascular and metabolic 
effects. In fact, it has been suggested that the criterion to be considered 
sedentary is independent of whether physical activities recommendations are met 
(Hamilton et al., 2008; Haskell et al., 2007; Healy et al., 2008; Pate et al., 1995). 
Several laboratory studies have concluded that physical activity and physical 
inactivity (sedentary) have different and unique effects on the body. For instance, 
molecular processes/mechanisms that are impaired by physical inactivity can be 
different from those that are activated by exercise (Bey et al., 2003; Bey & 
Hamilton, 2003; Simonen et al., 2003; Zderic & Hamilton, 2006).  
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Several studies have demonstrated the beneficial effects of FW running in rats, 
counteracting cardiovascular complications related to obesity (Judge et al., 2005; 
Lesniewski et al., 2013). Likewise, there are a considerable number of studies 
that state the positives effects induced by endurance TM exercise in cardiac 
function (for ref see Ascensao et al., 2007), including mitochondrial fitness (for 
ref see Antonio Ascensao et al., 2011). Moreover, mitochondrial dysfunction 
associated with aging and several pathological conditions, including obesity, 
diabetes, drug administration or isquemia-reperfusion like events were prevented 
by endurance exercise (Ascensao et al., 2006; Brown et al., 2003; Goncalves et 
al., 2015; Kavazis et al., 2008; Marques-Aleixo et al., 2015). 
In the present study, no differences in the running distance (daily mean per week) 
between the animals of the distinct diets engaged in FW running groups were 
found (Figure 5). This means that the differences found in cardiac mitochondria 
of FW animals must be related to diet treatment rather that exercise volume. 
 
6.3 Animal Characterization 
Regular physical exercise has been considered an effective strategy against 
obesity, promoting weight loss, visceral adiposity decrease, and lipid profile 
improvement, among others, leading to a decrease in obesity-induced-
cardiovascular complications and risk (Bruun et al., 2006; Hafstad et al., 2013).  
In the present study, no differences were found between SD and HFD in caloric 
intake and body weight, probably explained by the equal energetic value of the 
two diets, which is in accordance with previous studies (Goncalves et al., 2015; 
Lieber et al., 2004). However, HFD treated animals (HFD+Sed vs. SD+Sed) had 
increased visceral fat (mesenteric fat, Table 3) probably explained by the higher 
fat percentage of this diet (Goncalves et al., 2015). These results are in 
accordance with Estrany et al. (2011) in which a HFD led to increases in adipose 
tissue. 
The FW was able to decrease body weigh in SD, but had no effect in HFD treated 
animals, which is also in accordance with Goncalves et al. (2015). On the other 
hand, FW had a very positive effect in visceral adiposity, decreasing mesenteric 
fat in both diet treated groups, also demonstrated by the decreased in AI (Table 
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3). This confirms findings of other authors reporting that voluntary physical activity 
may be an efficient strategy to prevent visceral adiposity (Levin & Dunn-Meynell, 
2003). In our study, 17 weeks of FW running was enough to promote a preventive 
effect against visceral obesity, but promote no differences in body weight in HFD 
animals. On the other hand, Tm successfully decreased body weight, mesenteric 
fat and AI in both diet groups (Table 3), proving to be a potential therapeutic 
strategy against obesity (Ascensao et al., 2006; Irving et al., 2008). The increase 
in heart-to-body ratio in Tm running animals suggests a positive cardiovascular 
adaptation to this type of exercise (Ascensao et al., 2006). 
 
6.3.1. Serum markers 
Obesity has been associated with some clinical features that are recognized as 
risk factors for the development of cardiovascular diseases (for ref see Bastien 
et al., 2014). Nowadays, the development of these clinical features within an 
obesity context and its consequences in cardiovascular health has been 
previously and elegantly documented (Calligaris et al., 2013; Goncalves et al., 
2016). 
In contrast to some expectations, results from the present study show that 17 
weeks of HFD significantly decreased TG and VLDL plasma levels, while 
increasing HDL plasma level (table 4). A possible explanation to these results is 
that the present diet protocol was designed to induce NASH, and so, these 
unexpected alterations, mainly the VLDL and triglycerides plasma levels 
decreases are resultant from a possible hepatic injury (for ref see Goncalves et 
al., 2015).  
Concerning exercise, both interventions positively modulated TG and cholesterol 
levels in SD groups. However, despite the protective effect of physical activity in 
nonalcohololic fatty liver disease (NAFLD) and related metabolic disorders 
already demonstrated by others (Bhat et al., 2012; Goncalves et al., 2013), the 
results from HFD animals reveal that only FW positively modulated total 
cholesterol and VLDL levels at 9th week. Interestingly, the same did not occur at 
17th week. Furthermore, endurance Tm training did not promote any protective 
effect in blood lipid profile (table 4). Sullivan et al. (2012) concluded that 16 weeks 
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endurance training promoted a small decrease in intrahepatic TG and did not 
affect lipid kinetics, which suggest that endurance training may have only a 
modest therapeutic effect on hepatic TG and lipoprotein metabolism. In line with 
Sullivan et al. (2012), as Tm animals only exercised for 8 weeks, the duration of 
the Tm training intervention may not be enough to counteract the metabolic 
disarrangements induced by HFD treatment. Accordingly, Devries et al. (2008) 
reported the effects of endurance training on hepatic lipid content and adiposity 
in men and women. This research group also showed that endurance training did 
not lower hepatic lipid content, which suggest that in order to successfully 
decrease lipid content, an increase in intensity/duration and/or weight loss might 
be required.  
 
6.4 The effects of high-fat diet on cardiac mitochondrial bioenergetics, 
OXPHOS content and redox state  
Cardiac mitochondrial dysfunction induced by obesity and high-fat feeding in rats 
has been previously studied (Boudina & Abel, 2005; Essop et al., 2016; 
Goncalves et al., 2016; Kang et al., 2015; Sverdlov et al., 2015; Sverdlov et al., 
2016). Most of these studies showed that a HFD induces cardiac mitochondria 
dysfunction, linked to, decreased of ATP synthesis and oxygen consumption, 
decreased on maximal membrane , mitochondria uncoupling, with increased 
calcium concentration, and ultimately with increases in apoptotic stimuli. 
Additionally, as a consequence of obesity and HFD feeding, the increase in FA 
oxidation in the heart could be responsible for the excessive ROS production. 
This seems to be explained by the increased supply of reduced equivalents 
(NADH and FADH2) to the MRC without a correspondent OXPHOS capacity, that 
may result in the loss of electrons from the MRC and consequently generating 
additional ROS (Abdurrachim et al., 2014; Fillmore & Lopaschuk, 2013). Among 
the deleterious consequences of ROS generation, mitochondrial bioenergetics 
and the expression of OXPHOS proteins are negatively targeted (Boudina et al., 
2005; Ge et al., 2012).  
Mitochondria dysfunction induced by HFD feeding may contribute to the 
development of cardiac complications, such as diastolic dysfunction (Kang et al., 
2015). Cole et al. (2011) conducted a study in which a group of rodents were fed 
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a HFD (55% of energy provided from fat) and a control group was fed a chow diet 
for 3 weeks. These authors demonstrated an increase in fatty acid oxidation in 
cardiac mitochondria accompanied by mitochondrial uncoupling, increased 
mitochondrial oxygen consumption and consequently decreased cardiac 
efficiency. Abdurrachim et al. (2014) evaluated cardiac diastolic dysfunction in 
HFD (45% of energy provided from fat) fed mice and concluded that HFD induced 
an early stage cardiomyophaty associated to lipotoxicity-associated oxidative 
stress, fibrosis and disturbed calcium homeostasis rather than impaired cardiac 
energetics. However, the variety of diet protocols used, specifically diet 
composition of both high fat and control diets and duration of the protocols may 
interfere with the results, making it difficult to compare studies. Moreover, as 
stated before, these studies were focused in the effects of hypercaloric versus 
normocaloric diets, regardless the diet composition. 
In the present study, due to the differences in fat composition, a negative impact 
of HFD in cardiac mitochondrial functionality and redox balance was expected in 
comparison with SD+SED group. However, besides the significant decrease in 
ATP synthase in HFD (Figure 9), no other statistically difference was found 
between diet treatments in SED. 
The observed decrease in ATP synthase content does not implicate a decrease 
in mitochondrial respiratory activity (Brand & Nicholls, 2011), which is supported 
by the lack of negative impact in mitochondria oxygen consumption and 
transmembrane electric potential parameters in HFD treated animals. Our 
explanation for the divergent results is based on the argument that increases in 
protein expression do not implicate increases in their activity (Vogel & Marcotte, 
2012). Likewise, it can be assumed that the decrease in complex V content does 
not impose a decrease in their activity individually or in the overall process of 
mitochondrial respiration. Furthermore, Brand & Nicholls (2011) state that even 
moderate changes in individual complexes activity have little effects in the overall 
system behavior. 
A study from Kang et al. (2015) concluded that HFD feeding in a mouse model 
for 10 weeks resulted in a decrease in complex I, NUFB5 of OXPHOS subunit 
and a decrease in PGC-1 in cardiac mitochondria, a potent stimulator of 
mitochondrial biogenesis. An interesting study from Sverdlov et al. (2015) report 
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that 8 months of high fat- high sucrose diet induced cardiac mitochondrial 
dysfunction, decreasing in 70% the activity of complex II.  
As mentioned above, one of the most reported consequences of HFD is 
increased ROS production that, at least in part, is associated with cardiac 
mitochondrial impairments. Therefore, the lack of differences between diets in 
MDA content and glutathione redox status was not expected (Figure 10 and 11). 
Since the main component of mitochondria membranes are unsaturated FA that 
are highly prone to oxygen radical attack, the measurement of the lipid 
peroxidation product MDA is considered an indicator of oxidative stress. 
However, the use of a single oxidative damage marker and the analysis of a 
single antioxidant are important limitations of the present study. Hence, to better 
discuss the possible association between HFD and mitochondrial redox status 
other oxidative markers and antioxidants, including carbonyl groups and -SH, 
aconitase and Mn-SOD activity and measurement of the activity of proteins 
involved in mitochondrial oxidative stress (for instances SIRT3, p66shc and 
UCP2), as previously done by Marques-Aleixo et al. (2015), should be considered 
in future works.  
A possible explanation for the lack of results is the sequence by which organs are 
affected by obesity. Scientific evidence available indicates that liver is generally 
the first organ to be affected due to the increased delivery of free fatty acids and 
subsequent fat accumulation, resultant from the boosted lipolytic activity in 
visceral fat (Abdurrachim et al., 2014). Importantly, epidemiological evidences 
suggest that nonalcoholic fatty liver disease (NAFLD) has been associated with 
an increase of coronary heart disease, abnormalities of cardiac function and 
structure, including left ventricular dysfunction and hypertrophy, heart failure, 
among others. In other words, liver diseases are a good predictor of 
cardiometabolic dysfunctions (Ballestri et al., 2014; Bhatia et al., 2012; Birkenfeld 
& Shulman, 2014; Cornier et al., 2011). 
The NASH represents a marker and a mediator of increased cardiovascular risk 
(Bhatia et al., 2012). Among other factors, a positive association between hepatic 
fat and myocardial IR has been found, accompanied by reduced myocardial 
glucose uptake, increased plasma levels of adipocytokines and vascular 
adhesion molecules (Lautamaki et al., 2006). The association of increased FFA 
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availability and myocardial IR leads to cardiac metabolic inflexibility already 
explained in the introduction section, ultimately resulting in impaired cardiac 
function, which is demonstrated by producing less ATP per oxygen molecule 
consumed (ADP/O) (Bhatia et al., 2012). Furthermore, the excess of FFA supply 
may originate cardiac lipotoxicity, also mentioned in the introduction, which is 
associated with increased oxidative stress and subsequent mitochondrial 
dysfunction, cardiomyocyte apoptosis, and finally cardiac dysfunction (Peterson, 
2006; Witteles & Fowler, 2008). Since the protocol of the present study was 
initially designed to induce NASH, successfully achieving it, maybe it should have 
been applied for a longer time in order to induce, as well, cardiac mitochondrial 
alterations. 
 
6.5 The effects of exercise on cardiac mitochondrial bioenergetics, 
OXPHOS content and redox state 
Previous studies have shown the protective effect of exercise on the heart, 
evidencing the preventive and therapeutic potential of a regular practice of 
physical exercise, expanding its’ action to a clinical context (for ref see Ascensao 
et al., 2007). In accordance to the literature, physical exercise has been proven 
to be a great strategy to improve cardiac mitochondrial functionality, increasing 
antioxidant capacity, improving membrane integrity and consequently improving 
oxidative capacity (Alleman et al., 2015; Ascensao et al., 2007; Hai et al., 2008; 
Jacobs & Lundby, 2013; Kavazis et al., 2008).  
An important goal of this thesis was to understand whether exercise promotes 
improvements on cardiac mitochondrial function in animals fed a high-fat diet. 
Moreover the present study is also concerned with different exercise modalities 
frequently used in rodents studies.  
In order to be able to evaluate mitochondrial function, respiratory activity along 
with mitochondrial membrane potential and ADP-induced phosphorylation cycle 
were measured. An additional approach used in the present study was the 
quantification of complex I, II, IV and V from MRC and mitochondrial oxidative 
stress and antioxidant capacity. 
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The cardiac mitochondrial function data obtained in the present study are, at least 
in part, in accordance with the cardioprotective effects induced by exercise, 
particularly the endurance Tm training (for ref see Ascensao et al., 2007; Antonio 
Ascensao et al., 2011). In animals fed a standard diet, Tm running significantly 
improved cardiac mitochondrial function, as it increased RCR (Figure 6). 
Alterations in RCR are considered a good indicator of mitochondria 
function/dysfunction and structural integrity, as a high RCR score is related to a 
higher capacity for substrate oxidation and a low proton leak (Pesta & Gnaiger, 
2012). However, RCR scores depend on various factors. For instance, alterations 
in any aspect of OXPHOS will have an impact in RCR score (Brand & Nicholls, 
2011). The literature suggests that even short-term exercise protocols have a 
positive impact in this important functional parameter (Kavazis et al., 2010). 
Unexpectedly, the increased mitochondrial function evaluated by RCR paralleled 
a decrease in complex V content.  
Interestingly, after the anoxia-reoxygenation stimulus endurance trained animals 
fed with the SD revealed a protective effect demonstrated by the results in ADP/O 
and state 4 (Figure 8). Since state 4 significantly decreased, and as this value is 
mostly associated to proton leak, we can assume that Tm running had a positive 
effect in mitochondrial structural integrity or in maintaining a sufficient high 
membrane , thus restricting electron transport (Brand & Nicholls, 2011). In 
accordance to Brand & Nicholls (2011), alterations in ADP/O are usually related 
to coupling mechanisms, for example, complexes activity and their capacity of 
pumping more or less protons. Though, alterations in this parameter are also 
related to proton leak, which suggest that endurance Tm training seems to confer 
a protective phenotype against an isquemia-reperfusion event. The protective 
effect of 14 weeks of endurance exercise against anoxia-reoxygenation was 
reported by Ascensao et al. (2006), using an in vitro model similar to the used in 
the present study. 
The animals from HFD group assigned to the Tm protocol demonstrate a 
significant improvement in RCR before and after A-R (Figure 6 and 8). This 
suggests that endurance training improved mitochondrial fitness, particularly 
mitochondrial respiratory activity and mitochondrial ability to produce energy in a 
context of obesity and HFD feeding. The alterations in respiration resulting from 
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the endurance training may stem from increased expression of complex IV and 
V (Figure 9). If a long term HFD is associated with cardiac mitochondrial 
impairments, including OXPHOS content as seen by others (Kang et al., 2015; 
Sverdlov et al., 2015), Tm seems to have an important role in the cardiac 
protection against obesity-induced mitochondrial respiratory activity and overall 
dysfunction.  
On the other hand, FW was ineffective modulating mitochondrial respiratory 
activity in both SD and HFD groups (Figure 6). As suggested by to Bishop et al. 
(2014), the training intensity may be determinant for inducing improvements in 
mitochondrial respiration in skeletal muscle, which is consistent with our results 
in cardiac muscle. Although we do not know the exact intensity of FW, it is 
presumable that a higher intensity and lower volume training characterize Tm 
running compared to than FW. It is however important to note that previous 
studies from our group reported increased cardiac mitochondrial RCR in rodents 
submitted to 12 weeks of voluntary running (Marques-Aleixo et al., 2015). The 
animals from the present study in the last 6 weeks run about 2 km per day less 
that the animals from the study of Marques-Aleixo et al. (2015), which may be 
influenced by their weight (about 100 g more). We could speculate that HFD 
induced-obesity may act as suppressor of voluntary running volume, and 
therefore cardiac mitochondria respiratory adaptations. In contrast to 
mitochondrial oxygen consumption, FW had a stronger effect than Tm running in 
complex IV and V content in both SD and HFD-related animals. Despite these 
results do not translate into an increase in mitochondrial functionality, it may 
suggest that exercise volume might constitute a stimulus to increase OXPHOS 
proteins expression. 
The complementary study of  is indispensable for a complete analysis of 
mitochondrial function because it reflects the basic energetic relation to cellular 
homeostasis maintenance. In fact, the electrochemical gradient due the pumping 
of protons through the inner membrane (Murphy & Brand, 1988) is indispensable 
to ADP phosphorylation (Stock et al., 1999). Moreover, when cytosolic 
concentration of calcium increases, mitochondria act as calcium buffers due its 
capacity to uptake and accumulate calcium (Gunter et al., 2004). It has been 
suggested that intramitochondrial calcium concentration, whose flow is directed 
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in accordance with the protomotriz gradient, has a controlling function in 
metabolic rate of oxidative energy production through the activation of calcium-
sensitive dehydrogenases, F0F1ATPase and ANT (Glancy et al., 2013). Our 
results showed no alterations of maximal , depolarization, repolarization or the 
lag phase in cardiac mitochondria from exercise groups (Figure 7). It is however 
important to note that despite the inexistence of significant differences, in 
accordance to A. Ascensao et al. (2011) the  values above −200 mV did not 
seem to compromise ATP synthase flow or the transport of ions and metabolites. 
In addition, Kaim & Dimroth (1999) suggest that ATP synthase can only reach 
saturation at approximately -100mV (). Our results show that the range of  
varies between approximately -186mV and -215mV. The necessary time to 
restore membrane potential after addition and consequent ADP phosphorylation, 
e.g., the lag phase, seems to be modulated by exercise (Marques-Aleixo et al., 
2015). Unexpectedly, our results failed to show that exercise induces an increase 
in ADP phosphorylation.  
 
The literature support that intimately associated with cardiac mitochondrial 
improvements, chronic physical exercise improve the antioxidant machinery and 
consequently to decrease oxidative stress markers (Ascensao et al., 2007; 
Antonio Ascensao et al., 2011; Starnes & Taylor, 2007). This is particularly 
important, as heart has lower antioxidant defenses compared with other tissues 
(Chen et al., 1994). Exercise neither positively impacted cardiac mitochondrial 
lipid peroxidation or glutathione redox status in SD groups (Figure 10 and 11). 
These results are divergent from literature supporting the protective effects of 
endurance training on antioxidant potential (Ascensao et al., 2006; Ascensão et 
al., 2005; Bo et al., 2008; Hai et al., 2008; Starnes et al., 2007). 
Although there were no differences in MDA content between exercise groups and 
sedentary HFD, an increased GSH/GSSG ratio following 17 weeks of FW running 
suggest a positive modulation of the antioxidant machinery. Indeed, reduced 
glutathione (GSH) is considered to be one of the most important ROS 
scavengers, and its ratio with oxidized glutathione (GSSG) may be used as a 
marker of oxidative stress (Li et al., 2000; Rahman et al., 2006). Interestingly, FW 
also had a positive effect in complex IV and complex V content, and since 
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oxidative stress is related to lower expression of mitochondrial proteins, such as 
OXPHOS proteins (Boudina et al., 2005) it gives support to presume that this 
exercise model might constitute an efficient cardioprotective strategy in the 
context of HFD feeding. Corroborating with our results, Judge et al. (2005) 
conducted a study in which lifelong FW running decreased H2O2 production in 
cardiac mitochondria (the target for reduced glutathione) without improving 
mitochondrial rates of oxygen consumption or RCR. 
In contrast, Tm training did not promote the antioxidant protective effect that was 
expected. In fact, no alterations were found in GSH/GSSG ratio compared to 
SED+HFD group. Considering that differences were also not found in MDA 
content, as previously suggested in this discussion, the assay of other markers 
of mitochondrial redox state should give more confidence to these results. It is 
important to highlight that FW running seems to better regulate glutathione redox 
status than Tm training group. One possible reason for the differences found in 
the modulation of mitochondrial redox balance by Tm and FW within a context of 
a HFD could be the duration of the intervention of each exercise model. Animals 
engaged to the FW training exercised for 17 weeks, starting at the same time as 
diet protocol. On the opposite, Tm animals only exercised for 8 weeks and 8 
weeks after the beginning of HFD consumption.  
 
To our knowledge this is the first study comparing endurance training effects on 
cardiac mitochondrial bioenergetics and redox status of animals fed with a high-
fat diet. Therefore, more studies are required to elucidate important questions, 
more precisely the optimal training stimuli (intensity, volume, power, frequency 
and length of intervention) to better enhance heart mitochondrial fitness. 
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7. Conclusions  
 
In summary, the data from present dissertation provides additional support about 
the effect of two distinct physical exercise models (voluntary physical activity and 
endurance training) against the deleterious impact imposed on cardiac 
mitochondria by a high-fat diet.  
The following conclusions can be taken: 
• 17 weeks of HFD treatment did not induced significant alterations on 
heart mitochondrial function or redox state; 
• 8 weeks of endurance Tm training performed after 8 weeks of SD and 
HFD seems to positively modulate cardiac mitochondrial bioenergetics 
endpoints; 
• 17 weeks of FW running performed during the course of SD and HFD 
resulted in increased OXPHOS subunit content and GSH/GSSG ratio 
In summary, these finds suggest that exercise is likely to contribute a protective 
mitochondrial phenotype even in a context of HFD feeding. The knowledge of the 
mechanisms associated with the protective and/or therapeutic role of physical 
exercise in the set of physiological cardiovascular remodeling to counteract 
obesity side effects, should be further explored. 
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